open access research combining modifiable risk …2 peters r etfial m open 20199e022846...

22
1 Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846 Open access Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis Ruth Peters, 1,2,3 Andrew Booth, 4 Kenneth Rockwood, 5 Jean Peters, 4 Catherine D'Este, 6,7 Kaarin J Anstey 1,3 To cite: Peters R, Booth A, Rockwood K, et al. Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis. BMJ Open 2019;9:e022846. doi:10.1136/ bmjopen-2018-022846 Prepublication history and additional material for this paper are available online. To view these files, please visit the journal online (http://dx.doi. org/10.1136/bmjopen-2018- 022846). Received 16 March 2018 Revised 9 August 2018 Accepted 15 November 2018 1 Neuroscience Research Australia, Sydney, New South Wales, Australia 2 School of Public Health, Imperial College London, London, UK 3 University of New South Wales, Sydney, New South Wales, Australia 4 School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK 5 Dalhousie University, Halifax, Nova Scotia, Canada 6 Australian National University (ANU), Canberra, Australian Capital Territory, Australia 7 University of Newcastle, Callaghan, New South Wales, Australia Correspondence to Dr Ruth Peters; [email protected] Research © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ABSTRACT Objective To systematically review the literature relating to the impact of multiple co-occurring modifiable risk factors for cognitive decline and dementia. Design A systematic review and meta-analysis of the literature relating to the impact of co-occurring key risk factors for incident cognitive decline and dementia. All abstracts and full text were screened independently by two reviewers and each article assessed for bias using a standard checklist. A fixed effects meta-analysis was undertaken. Data sources Databases Medline, Embase and PsycINFO were searched from 1999 to 2017. Eligibility criteria For inclusion articles were required to report longitudinal data from participants free of cognitive decline at baseline, with formal assessment of cognitive function or dementia during follow-up, and an aim to examine the impact of additive or clustered comorbid risk factor burden in with two or more core modifiable risk factors. Results Seventy-nine full-text articles were examined. Twenty-two articles (18 studies) were included reporting data on >40 000 participants. Included studies consistently reported an increased risk associated with greater numbers of intraindividual risk factors or unhealthy behaviours and the opposite for healthy or protective behaviours. A meta-analysis of studies with dementia outcomes resulted in a pooled relative risk for dementia of 1.20 (95% CI 1.04 to 1.39) for one risk factor, 1.65 (95% CI 1.40 to 1.94) for two and 2.21 (95% CI 1.78 to 2.73) for three or more, relative to no risk factors. Limitations include dependence on published results and variations in study outcome, cognitive assessment, length of follow-up and definition of risk factor exposure. Conclusions The strength of the reported associations, the consistency across studies and the suggestion of a dose response supports a need to keep modifiable risk factor exposure to a minimum and to avoid exposure to additional modifiable risks. Further research is needed to establish whether particular combinations of risk factors confer greater risk than others. PROSPERO registration number 42016052914. BACKGROUND   Modifiable risk factors for cognitive decline and dementia are now well established and several are similar to those for cancer and cardiovascular disease. 1 2 In particular, these include smoking, low physical activity, sedentary lifestyle, poor diet, excess alcohol consumption, midlife obesity, high blood pressure, midlife high cholesterol and diabetes. Depression, low social engagement and low cognitive engagement have also been linked to risk of late-life dementia. 1 2 To date, the literature linking such risk factors to incident cognitive decline and dementia has typically focused on the rela- tionship between an individual risk factor and later cognitive outcome. Despite this, we know that the clustering or co-occurring of risk factors is the more likely scenario. 3–5 Population observed risk factor clusters typi- cally include smoking, excess alcohol intake, poor diet and low levels of exercise. 3–5 However, although the best evidence for reduction in risk of cognitive decline comes from multifactorial clinical trials targeting multiple risk factors, 6 there remains a lack of knowledge relating to the impact of risk factor burden and its composition. Targeting of effective public health risk Strengths and limitations of this study This is the first systematic robust evaluation of the evidence relating to impact of co-occurring modifi- able risk factors for incident dementia and cognitive decline. Strengths of this review include use of Cochrane- based methodology with a robust search strategy, detailed search terms and successful coverage of the data resulting in representation of study popula- tions from 18 studies and 9 countries across Europe, Australia and North America with >40 000 partici- pants and follow-up from midlife and late life. Limitations include a lack of representation from other parts of the world and a restricted opportunity for evidence synthesis due to variability in reporting of individual study results. Data were able to be combined for 5 of the 18 studies. on June 23, 2020 by guest. Protected by copyright. http://bmjopen.bmj.com/ BMJ Open: first published as 10.1136/bmjopen-2018-022846 on 25 January 2019. Downloaded from

Upload: others

Post on 17-Jun-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

1Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis

Ruth Peters,1,2,3 Andrew Booth,4 Kenneth Rockwood,5 Jean Peters,4 Catherine D'Este,6,7 Kaarin J Anstey1,3

To cite: Peters R, Booth A, Rockwood K, et al. Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

► Prepublication history and additional material for this paper are available online. To view these files, please visit the journal online (http:// dx. doi. org/ 10. 1136/ bmjopen- 2018- 022846).

Received 16 March 2018Revised 9 August 2018Accepted 15 November 2018

1Neuroscience Research Australia, Sydney, New South Wales, Australia2School of Public Health, Imperial College London, London, UK3University of New South Wales, Sydney, New South Wales, Australia4School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK5Dalhousie University, Halifax, Nova Scotia, Canada6Australian National University (ANU), Canberra, Australian Capital Territory, Australia7University of Newcastle, Callaghan, New South Wales, Australia

Correspondence toDr Ruth Peters; r. peters@ imperial. ac. uk

Research

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

AbstrACtObjective To systematically review the literature relating to the impact of multiple co-occurring modifiable risk factors for cognitive decline and dementia.Design A systematic review and meta-analysis of the literature relating to the impact of co-occurring key risk factors for incident cognitive decline and dementia. All abstracts and full text were screened independently by two reviewers and each article assessed for bias using a standard checklist. A fixed effects meta-analysis was undertaken.Data sources Databases Medline, Embase and PsycINFO were searched from 1999 to 2017.Eligibility criteria For inclusion articles were required to report longitudinal data from participants free of cognitive decline at baseline, with formal assessment of cognitive function or dementia during follow-up, and an aim to examine the impact of additive or clustered comorbid risk factor burden in with two or more core modifiable risk factors.results Seventy-nine full-text articles were examined. Twenty-two articles (18 studies) were included reporting data on >40 000 participants. Included studies consistently reported an increased risk associated with greater numbers of intraindividual risk factors or unhealthy behaviours and the opposite for healthy or protective behaviours. A meta-analysis of studies with dementia outcomes resulted in a pooled relative risk for dementia of 1.20 (95% CI 1.04 to 1.39) for one risk factor, 1.65 (95% CI 1.40 to 1.94) for two and 2.21 (95% CI 1.78 to 2.73) for three or more, relative to no risk factors. Limitations include dependence on published results and variations in study outcome, cognitive assessment, length of follow-up and definition of risk factor exposure.Conclusions The strength of the reported associations, the consistency across studies and the suggestion of a dose response supports a need to keep modifiable risk factor exposure to a minimum and to avoid exposure to additional modifiable risks. Further research is needed to establish whether particular combinations of risk factors confer greater risk than others.PrOsPErO registration number 42016052914.

bACkgrOunD   Modifiable risk factors for cognitive decline and dementia are now well established and several are similar to those for cancer

and cardiovascular disease.1 2 In particular, these include smoking, low physical activity, sedentary lifestyle, poor diet, excess alcohol consumption, midlife obesity, high blood pressure, midlife high cholesterol and diabetes. Depression, low social engagement and low cognitive engagement have also been linked to risk of late-life dementia.1 2

To date, the literature linking such risk factors to incident cognitive decline and dementia has typically focused on the rela-tionship between an individual risk factor and later cognitive outcome. Despite this, we know that the clustering or co-occurring of risk factors is the more likely scenario.3–5 Population observed risk factor clusters typi-cally include smoking, excess alcohol intake, poor diet and low levels of exercise.3–5 However, although the best evidence for reduction in risk of cognitive decline comes from multifactorial clinical trials targeting multiple risk factors,6 there remains a lack of knowledge relating to the impact of risk factor burden and its composition. Targeting of effective public health risk

strengths and limitations of this study

► This is the first systematic robust evaluation of the evidence relating to impact of co-occurring modifi-able risk factors for incident dementia and cognitive decline.

► Strengths of this review include use of Cochrane-based methodology with a robust search strategy, detailed search terms and successful coverage of the data resulting in representation of study popula-tions from 18 studies and 9 countries across Europe, Australia and North America with >40 000 partici-pants and follow-up from midlife and late life.

► Limitations include a lack of representation from other parts of the world and a restricted opportunity for evidence synthesis due to variability in reporting of individual study results.

► Data were able to be combined for 5 of the 18 studies.

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 2: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

2 Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

reduction strategies for cognitive decline and dementia first requires identification of the ‘at-risk’ population. This, in turn, requires an understanding of the impact of co-occurring modifiable risk factors and the role of risk factor combinations or clusters (commonly occur-ring risk factor combinations) on incident dementia and cognitive decline.

Our objective is to systematically examine the litera-ture addressing clustering or co-occurring modifiable risk factors for incident cognitive decline and dementia within individuals, and to estimate, using meta-analysis, the impact of exposure to one or more modifiable risk factors compared with absence of risk factors on the risk of future cognitive decline and dementia.

MEthODsThe databases Medline, Embase and PsycINFO were searched for articles published between January 1999 and March 2017 using the search terms (cluster* or cluster analysis or summative or score or scoring or scale or scales or measure or measurement or additive or cumulative) AND (dementia or Alzheimer* or cognitive or cognition disorders) AND risk factors, limited to Adults and English language publications. See online supplementary text 1 for details. To maximise identification of eligible studies, online supplementary focused electronic searches were undertaken to include scoring-related terms and clus-ter-related terms separately with risk factors, vascular risk factors and ‘vrf’. Reference lists of the included articles were also reviewed (online supplementary text 1).

Inclusion criteria ► Longitudinal studies with an explicit aim to examine

the impact of additive or clustered modifiable risk factor burden for combinations of multiple core modifiable dementia risk factors (hypertension or high blood pressure, hypercholesterolaemia or high cholesterol, diabetes, high body mass index, smoking, excess alcohol, low physical activity and poor diet).

► Some evidence or clear implication that participants were free of cognitive decline or dementia at baseline assessment.

► Use of formal assessment of cognitive function or dementia or clear implication that formal dementia diagnosis took place (eg, cognitive decline assessed using general screening or neuropsychological testing, dementia diagnosis using standard diagnostic tools).

► Report of cognitive decline or dementia outcomes.

Exclusion criteria ► Non-English publications (in the absence of resources

for translation). ► Studies based solely on medical records without

systematic assessment of risk factors. ► Since the modifiable risk factors for dementia are

primarily thought to commence their influence from

early adult to mid-adult life, publications relating to non-adult populations were excluded.

► Publications with delirium as a primary end point and those including populations with cerebral auto-somal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADISIL) were excluded. Delirium is associated with acute cognitive decline and CADISIL populations have particular risk factor char-acteristics and are at high risk of subcortical dementia occurring in middle age or early old age.

► Publications reporting results for metabolic syndrome as a unitary risk factor were excluded. Metabolic syndrome represents a single particular cluster of vascular risk factors (usually defined as a requirement for 3/5 from obesity, high blood pressure, high plasma glucose, high serum triglycerides, low high-density lipoprotein levels) and its impact has already been examined systematically.7 8

► As we were seeking to examine the impact of modi-fiable risk factors, we excluded studies that included non-modifiable risk factors as an integral part of their risk measure, that is, where we could not evaluate the impact of modifiable risk factor burden.

► Finally, we excluded comments, letters, editorials, guidelines, consensus documents and conference proceedings.

Search strategies were co-designed by a qualified infor-mation professional (AB) and the principal investigator (RP) who conducted the literature searches. Screening of abstracts, or titles where abstracts were unavailable, was performed independently by two reviewers (RP, JP) with each reviewer compiling a list of studies for potential inclusion. The two reviewers compared lists with differ-ences being resolved by discussion. Full-text copies of the selected papers were obtained by the principal investi-gator and assessed independently for inclusion by each reviewer. Reference lists of the selected manuscripts were screened to identify other potentially relevant published papers.

Data were extracted independently by each reviewer and included papers were independently assessed for quality by both reviewers. An overall agreed risk of bias judgement was arrived at by consensus. A formal quality scoring scheme was not used as these can have poor discriminant ability; however, each paper was assessed against the key factors adapted from the Critical Appraisal Skills Programme checklists for evaluating randomised controlled trials and cohort studies, respectively (http://www. casp- uk. net/ casp- tools- checklists).

Data relating to the population reported in each study (number, age at baseline, % female at baseline), plus length of follow-up, risk factors included and where applicable, cut-off points used to define presence of risk factor, cognitive outcomes, methods of risk factor combi-nation and analysis, covariates and reported results were extracted to a standard data extraction form. Where various versions of the results were available, the most conservative, most adjusted results were selected. Narrative

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 3: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

3Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

synthesis was applied to describe and summarise the results of the included studies. Where summary measures included OR, HR or relative risks (RR), data relating to impact of clustering, defined as specific co-occurring risk factors or number of co-occurring modifiable risk factors were combined using meta-analytic techniques. The I2 measure was used to assess the percentage of variation across studies due to heterogeneity rather than chance. Where possible, publication bias was also examined using Egger’s test and visual inspection of funnel plots.

The protocol for this review is registered with PROS-PERO: the International prospective register of system-atic reviews CRD42016052914. Published data were used. Neither ethical approval nor consent for participation or publication was required.

Patient involvementWe acknowledge the importance of patient/carer/lay person involvement in research. Although patients/service users/lay people were not involved directly in the design of this systematic review, the development of the research question was supported and informed by several discussions held by the first author with older adult patient, carer and lay person groups on the subject of modifiable risk factors for dementia. As this was a review of published literature, there are no direct study partic-ipants and no opportunity to involve patients/carers or lay people in the development of outcome measures or in recruitment. We have thanked all participants of the contributing studies in the acknowledgements section and will be disseminating results to both lay and scientific audiences via presentations, publications and interna-tional dementia organisations.

rEsultsThe main systematic literature search resulted in 8916 records for review. The two supplementary focused elec-tronic searches yielded 970 and 2870 records (supple-mentary text 1 shows all search strategies). A further 10 references were identified from reference lists and expert recommendation. Abstract review resulted in 101 records retained for full-text evaluation (figure 1). Seven-ty-nine records were excluded: 8 because it was unclear whether the sample populations had been free of cogni-tive decline at baseline,9–16 9 due to a lack of appropriate cognitive outcomes,17–25 49 due to a lack of appropriate risk factor data, combining modifiable and non-modifi-able risk factors or where risk factor relationships were not evaluated.26–74 Eleven were not longitudinal75–85; one was a review article86 and one a commentary.87 Twenty-two articles relating to 18 cohort studies were included in the review.88–109 There were two studies with multiple publi-cations: the Whitehall II study106 107 and the Washington Heights Ageing Project.89 94 97 The articles differed in inclusion of risk factors, outcomes and analysis methods and so all were reported in the narrative results. Six studies reported risk ratios for risk factor exposure and

incident dementia or Alzheimer’s disease (AD) allowing meta-analyses.88 89 93 98 100 101

study characteristicsThe included studies totalled over 40 000 individuals recruited from high-income countries: the USA,88–97 Sweden,98–100 Finland,101 the Netherlands,102 103 Germany,104 France,105 the UK,106 107 Australia108 and Korea109 (table 1). Study sample sizes ranged from 322102 to 8845.93 Two studies recruited only men88 98 and for five articles, >50% of the participants were male.95 102 103 106 107 There were no female-only studies. Study follow-up varied from 22 months92 to over 20 years.88 90 93 96 101 Detailed compar-ison of follow-up is difficult, as different articles provided the information in differing ways. However, a broad cate-gorisation can be made into very short follow-up, esti-mated at <5 years,92 109 short follow-up, estimated at >5–10 years,89 94 95 99 100 104 106 108 moderate follow-up, estimated at >10–20 years91 97 98 102 103 105 107 and long follow-up, estimated at >20 years.88 90 93 96 101 There were 12 articles where baseline measures were taken in midlife (>40 and ≤65 years)88 93 96 98 99 101–103 105–108 and 9 articles where the baseline was in late life (>65 years).89 91 92 94 95 97 100 104 109 One study included those in earlier adult life with base-line age ~26 years.90

Cognitive outcomesEight manuscripts reported on dementia outcomes using standard diagnostic criteria,88 89 95 97 98 100 101 1032 used a dementia diagnosis made as part of medical treatment but did not give details of diagnostic criteria,93 1045 reported results specifically for AD88 89 97 98 100 and 12 reported on non-dementia cognitive outcomes. Cognitive measures included use of a screening test92 109 or a neuropsycho-logical battery.91 94 96 99 102 105–108 See table 2 for details of the diagnostic criteria and assessment tools used by each study.

risk factor measurementArticles varied in their selection of risk factors and the risk factors varied in number (from 2 to 13) and definition. See table 1 and online supplementary table 1 for details of risk factors included in each study and the cutpoints used to define presence of risk factors. Substantial overlap was identified for coverage of risk factors between studies; the most commonly included risk factors being smoking and hypertension or high blood pressure, although no single risk factor was common to all studies (table 1).

Different analyses aggregated risk factors or unhealthy behaviours or protective factors or healthy behaviours in different ways (table 2). Three used some form of clus-tering, cluster analysis, latent factors or principal compo-nent analysis and examined the relationship between membership of each cluster and cognitive outcome,95 99 105 15 studies categorised each risk factor as present or absent (1 or 0) and then generated a variable which was the total number of risk factors present.88–94 96 98 100 101 104 107–109 Three elaborated further by creating a weighted risk

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 4: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

4 Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

score97 102 103 and one used categories to combine two risk factors (alcohol and smoking) to examine additive impact.106

In general, studies used either linear, logistic or Cox proportional hazard regression (tables 2 and 3) to examine the relationship between baseline risk and cognitive outcomes; one study used latent growth curves106 and one provided graphical results only.96 Five studies looked at the inverse of risk factors and reported on protective or ideal health behaviours.90 91 97 104 109 Most studies adjusted for age, sex and education and/or socioeconomic status (tables 2 and 3); one adjusted for age and sex only102; one for sex only91; one for patterns of test completion and sex and in one case no information on the method of covariate adjustment was provided.96

Association between risk factors and cognitive outcomes and/or dementiaStudy findings showed remarkable similarity with the majority reporting a relationship between exposure to increased risk factor load and subsequent poorer cogni-tive function or dementia (table 3). No clear differences of results were observed by baseline age group, that is, cohorts in midlife or late-life at baseline, or for length of follow-up, although the varied presentation of study results meant that formal statistical testing could not be performed.

Eleven articles reported a relationship between risk factors and cognitive outcomes88 89 92 93 96 98–103; three between unhealthy behaviours105–107 and poorer cogni-tive outcomes; three reported a relationship between protective factors97 104 109 and two between ideal health

Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart detailing the number of records included at each stage of the review.

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 5: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

5Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

Tab

le 1

C

hara

cter

istic

s of

22

stud

ies

incl

uded

in s

yste

mat

ic r

evie

w

Stu

dy

nam

eP

op

ulat

ion

Ag

e at

bas

elin

eM

ean

(SD

) unl

ess

oth

erw

ise

stat

ed

Youn

g a

dul

t lif

e, m

idlif

e o

r la

te-l

ife

bas

elin

eP

er c

ent

fem

ale

Follo

w-u

pM

ean

(SD

) unl

ess

oth

erw

ise

stat

edR

isk

fact

or

dat

a

Bet

ula

Stu

dy99

Sam

ple

d fr

om t

he p

opul

atio

n re

gist

ry in

U

mea

, Nor

th S

wed

en. N

=87

9 w

ave

1,

n=75

6 w

ave

2, n

=61

3 w

ave

3

Orig

inal

ly s

amp

led

10

age

coho

rts

of n

=10

0, e

ach

5 ye

ars

apar

t, c

ohor

t 1

bor

n in

195

3–19

54 c

ohor

t 10

bor

n in

190

8–19

09.

Mea

n at

wav

e 1

56.2

5 (1

4.09

) ran

ge 3

5–80

Mid

life

52D

ata

colle

ctio

n ev

ery

5 ye

ars

from

198

8. D

ata

from

wav

es 1

–3 u

sed

. ~

10-y

ear

follo

w-u

p

Mul

tiple

fact

ors

mea

sure

d fo

r us

e in

prin

cip

al c

omp

onen

ts a

naly

ses:

to

tal s

erum

cho

lest

erol

, trig

lyce

rides

, th

yrox

ine,

thy

roid

-stim

ulat

ing

horm

one,

B

12, f

olat

e (B

9), a

lbum

in, h

aem

oglo

bin

, er

ythr

ocyt

e se

dim

enta

tion

rate

, gl

ucos

e, h

aem

oglo

bin

A1c

, res

ting

syst

olic

and

dia

stol

ic b

lood

pre

ssur

e,

bod

y m

ass

ind

ex (B

MI).

Cac

he C

ount

y S

tud

y 95

Pop

ulat

ion-

bas

ed c

omm

unity

sam

ple

of

old

er a

dul

ts in

Cac

he C

ount

ry U

tah,

US

A.

n=24

91

73.0

(5.7

)La

te-l

ife49

6.3

(5.3

) yea

rsS

mok

ing,

alc

ohol

inta

ke, d

iet,

phy

sica

l ac

tivity

, soc

ial i

nter

actio

n, c

hurc

h at

tend

ance

.

Car

dio

vasc

ular

Ris

k Fa

ctor

s, A

gein

g an

d

Dem

entia

(CA

IDE

) st

udy10

1

Ran

dom

pop

ulat

ion-

bas

ed s

amp

le. D

ata

colle

ctio

n in

mid

life

in 1

972,

197

7, 1

982,

19

87. T

hose

ind

ivid

uals

stil

l aliv

e ag

ed

65–7

0 ye

ars

at t

he e

nd o

f 199

7 an

d li

ving

in

tw

o ge

ogra

phi

cally

defi

ned

are

as in

or

clos

e to

the

tow

ns o

f Kuo

pio

and

Joe

nsuu

, Fi

nlan

d w

ere

targ

eted

for

follo

w-u

p. A

ra

ndom

sam

ple

of 2

000

invi

ted

for

re-

exam

inat

ion

in 1

998.

Sam

ple

n=

1449

Bas

elin

e 50

.6 (6

.0),

follo

w-u

p 7

1.6

(4.1

)M

idlif

e62

21 (4

.9) y

ears

Sys

tolic

and

dia

stol

ic b

lood

pre

ssur

e (B

P),

BM

I, to

tal c

hole

ster

ol.

Cor

onar

y A

rter

y R

isk

Dev

elop

men

t in

Yo

ung

Ad

ults

90

Bla

ck a

nd w

hite

ad

ults

rec

ruite

d fr

om fo

ur

US

citi

es (i

n fo

ur s

tate

s A

lab

ama,

Illin

ois,

M

inne

sota

, Cal

iforn

ia).

Pop

ulat

ion

sam

ple

s b

alan

ced

with

in e

ach

cent

re fo

r ag

e (1

8–24

/25–

30),

sex,

rac

e an

d e

duc

atio

n. 4

4.8%

b

lack

. n=

2932

~26

Youn

g ad

ult

life

5525

yea

rs. A

sses

smen

ts o

f d

ieta

ry in

take

at

bas

elin

e,

7, 2

0 ye

ars,

BP,

tot

al

chol

este

rol,

gluc

ose

at

bas

elin

e, 7

, 25

year

s,

cogn

itive

func

tion

at

25 y

ears

Sm

okin

g, p

hysi

cal a

ctiv

ity, t

otal

ch

oles

tero

l, fa

stin

g gl

ucos

e, B

MI,

die

t,

syst

olic

and

dia

stol

ic B

P.

Fram

ingh

am S

tud

y96P

opul

atio

n-b

ased

long

itud

inal

stu

dy,

US

A.

From

the

sam

ple

of 2

123

adm

inis

tere

d

the

neur

opsy

chol

ogic

al b

atte

ry a

t ex

am

14/1

5, 1

974–

1978

, tho

se w

ithou

t p

rior

stro

ke, d

emen

tia, c

ard

iova

scul

ar d

isea

se

or e

vent

(inc

lud

es m

yoca

rdia

l inf

arct

ion,

an

gina

pec

toris

, con

gest

ive

hear

t fa

ilure

, in

term

itten

t cl

aud

icat

ion,

cor

onar

y in

suffi

cien

cy) w

ere

sele

cted

. Ana

lytic

al

sam

ple

n=

1423

Wom

en 6

7.2

(7.3

), m

en

55.7

(6.9

), (r

ange

55–

88)

Mid

life

61~

30 y

ears

. Vis

its e

very

2

year

s fr

om 1

948

until

ne

urop

sych

olog

ical

te

stin

g in

197

4–19

78

Ob

esity

and

hyp

erte

nsio

n as

sess

ed

from

195

4.

Hon

olul

u A

sia

Age

ing

Stu

dy88

Jap

anes

e A

mer

ican

men

res

idin

g in

H

onol

ulu,

Haw

aii,

in 1

965.

Sam

ple

n=

3555

Bas

elin

e, m

ean

52.7

(4.5

). Fo

llow

-up

, mea

n 77

.8

(4.6

)

Mid

life

019

65–1

991–

1993

(~

27 y

ears

)S

ysto

lic a

nd d

iast

olic

BP,

BM

I, ra

ndom

tr

igly

cerid

es, t

otal

cho

lest

erol

, pos

t lo

ad g

luco

se, s

ubsc

apul

ar s

kinf

old

th

ickn

ess.

Con

tinue

d

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 6: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

6 Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

Stu

dy

nam

eP

op

ulat

ion

Ag

e at

bas

elin

eM

ean

(SD

) unl

ess

oth

erw

ise

stat

ed

Youn

g a

dul

t lif

e, m

idlif

e o

r la

te-l

ife

bas

elin

eP

er c

ent

fem

ale

Follo

w-u

pM

ean

(SD

) unl

ess

oth

erw

ise

stat

edR

isk

fact

or

dat

a

Hoo

rn S

tud

y102

Gen

eral

pop

ulat

ion

stud

y. T

he N

ethe

rland

s.

On

gluc

ose

met

abol

ism

. n=

322

55.9

(3.7

), (r

ange

50–

75)

Mid

life

4919

89–2

008

CA

IDE

dem

entia

sco

re; m

odifi

able

ris

k fa

ctor

s, s

ysto

lic B

P, B

MI,

chol

este

rol,

phy

sica

l act

ivity

.

Inte

rven

tion

pro

ject

on

cer

ebro

vasc

ular

d

isea

se a

nd

dem

entia

in

the

dis

tric

t of

E

ber

sber

g104

Pop

ulat

ion-

bas

ed c

ohor

t st

udy.

Ger

man

y.

n=35

4767

.3 (7

.6)

Mid

life

5920

01–2

003–

2008

Sys

tolic

and

dia

stol

ic B

P, s

mok

ing,

B

MI,

phy

sica

l act

ivity

, tot

al c

hole

ster

ol,

fast

ing

gluc

ose.

Kai

ser

Per

man

ente

M

edic

al C

are

Pro

gram

93

Kai

ser

Per

man

ente

is a

non

-pro

fit h

ealth

d

eliv

ery

syst

em w

ith m

emb

ers

that

are

re

pre

sent

ativ

e of

the

loca

l pop

ulat

ion.

US

A.

n=88

45

42. F

or t

hose

who

re

mai

ned

with

out

dia

gnos

is o

f dem

entia

: 42

.0 (1

.4).

For

thos

e w

ho w

ent

on t

o ga

in a

d

iagn

osis

of d

emen

tia:

42.3

(1.4

). R

ange

40–

44

Mid

life

54M

ean

26.7

yea

rs 1

964–

1973

–200

3S

ysto

lic a

nd d

iast

olic

BP,

dia

bet

es,

chol

este

rol,

smok

ing.

Kun

gsho

lmen

p

roje

ct10

0R

ecru

ited

tho

se a

ged

75

year

s an

d o

ver

livin

g in

Kun

gsho

lmen

in S

tock

holm

, S

wed

en, i

n O

ctob

er 1

987.

Bas

elin

e n=

1810

, inc

lud

ed in

ana

lyse

s n=

1270

81.5

(5.0

)La

te-l

ife75

Mea

n 5.

1 (m

axim

um 1

0.5)

ye

ars,

vis

its in

198

7/19

99,

1991

/199

3, 1

994/

1996

an

d 1

997/

1998

Sys

tolic

and

dia

stol

ic B

P, p

ulse

p

ress

ure,

med

ical

his

tory

and

m

edic

atio

n d

ata

from

med

ical

rec

ord

s.

Maa

stric

ht A

gein

g S

tud

y103

Pop

ulat

ion-

bas

ed c

ohor

t st

udy,

The

N

ethe

rland

s. n

=94

965

.0 (8

.7),

>55

Mid

life

4912

yea

rs. F

rom

199

3 to

19

95A

wei

ghte

d r

isk

scor

e ‘L

ifest

yle

for

Bra

in H

ealth

’ cre

ated

usi

ng s

tand

ard

te

chni

que

s an

d 1

1 ris

k fa

ctor

s: lo

w/

mod

erat

e al

coho

l con

sum

ptio

n,

coro

nary

hea

rt d

isea

se, p

hysi

cal

inac

tivity

, ren

al d

ysfu

nctio

n, d

iab

etes

, hi

gh c

hole

ster

ol, s

mok

ing,

ob

esity

, hy

per

tens

ion,

dep

ress

ion,

hig

h co

gniti

ve a

ctiv

ity.

Per

sona

lity

And

Tot

al

Hea

lth, P

ath

thro

ugh

life

stud

y108

Long

itud

inal

coh

ort

stud

y, A

ustr

alia

. P

artic

ipan

ts w

ere

recr

uite

d fr

om t

he

elec

tora

l rol

e, n

=25

30

~42

.6 (r

ange

40–

44)

Mid

life

538

year

sD

iab

etes

, sys

tolic

BP,

sm

okin

g,

dep

ress

ion,

phy

sica

l act

ivity

, BM

I.

San

Lui

s Va

lley

Hea

lth a

nd A

ging

S

tud

y92

Pop

ulat

ion-

bas

ed s

tud

y of

hea

lth a

nd

dis

abili

ty in

the

His

pan

ic a

nd n

on-H

isp

anic

w

hite

pop

ulat

ion,

US

A?

n=14

44 a

t b

asel

ine,

n=

787

with

follo

w-u

p, w

ithou

t co

gniti

ve im

pai

rmen

t (M

ini-

Men

tal S

tate

E

xam

inat

ion

(MM

SE

)≥24

) and

with

ca

rdio

met

abol

ic m

easu

res

His

pan

ic 7

1.0

(5.9

), w

hite

72

.7 (7

.5)

Late

-life

His

pan

ic

58, w

hite

60

22 m

onth

sD

iab

etes

, cen

tral

ob

esity

, hyp

erte

nsio

n.

Tab

le 1

C

ontin

ued

Con

tinue

d

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 7: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

7Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

Stu

dy

nam

eP

op

ulat

ion

Ag

e at

bas

elin

eM

ean

(SD

) unl

ess

oth

erw

ise

stat

ed

Youn

g a

dul

t lif

e, m

idlif

e o

r la

te-l

ife

bas

elin

eP

er c

ent

fem

ale

Follo

w-u

pM

ean

(SD

) unl

ess

oth

erw

ise

stat

edR

isk

fact

or

dat

a

Sup

ple

men

tatio

n en

vi

tam

insv

itam

ines

et

min

erau

x an

tioxy

dan

ts

stud

y105

Par

ticip

ants

from

the

Sup

ple

men

tatio

n en

vi

tam

ines

et

min

erau

x an

tioxy

dan

ts t

rial,

Fran

ce, w

ho c

onse

nted

to

a p

ost-

tria

l ob

serv

atio

nal f

ollo

w-u

p s

tud

y. T

he t

rial r

an

in 1

994–

2002

and

rec

ruite

d 1

2 74

1 he

alth

y ad

ults

. Ob

serv

atio

nal s

tud

y fo

llow

-up

too

k p

lace

in 2

007–

2009

in 6

850.

Sam

ple

use

d

in t

hese

ana

lyse

s n=

2430

Follo

w-u

p 6

5.6

year

s (4

.5)

Mid

life

4513

(0.7

) yea

rsS

mok

ing,

phy

sica

l act

ivity

, alc

ohol

in

take

, sed

enta

ry b

ehav

iour

, BM

I, ve

geta

ble

inta

ke, s

eafo

od in

take

.

Suw

on L

ongi

tud

inal

A

gein

g S

tud

y109

Sam

ple

of c

omm

unity

dw

ellin

g ad

ults

age

d

65 y

ears

and

ove

r, S

outh

Kor

ea. S

amp

le

n=53

7 at

yea

r 3

73.0

(5.7

)La

te-l

ife61

3 ye

ars

Sm

okin

g, p

hysi

cal a

ctiv

ity, v

eget

able

co

nsum

ptio

n, a

lcoh

ol c

onsu

mp

tion,

so

cial

act

ivity

.

The

Nor

ther

n M

anha

ttan

Stu

dy91

A s

ubsa

mp

le n

=10

91 a

ged

>50

yea

rs w

ith

whi

te, b

lack

or

His

pan

ic e

thni

city

dra

wn

from

a p

opul

atio

n-b

ased

coh

ort

iden

tified

fr

om r

and

om d

igit

dia

lling

and

incl

udin

g th

ose

resi

din

g in

Nor

ther

n M

anha

ttan

, U

SA

, for

>3

mon

ths,

with

a t

elep

hone

and

w

ith n

o p

rior

stro

ke. n

=72

2 w

ith fo

llow

-up

. n=

638

with

follo

w-u

p a

nd w

ithou

t co

gniti

ve

imp

airm

ent

at b

asel

ine

71.7

(8.4

) at

first

ne

urop

sych

olog

ical

as

sess

men

t

Late

-life

61~

12 y

ears

. Fro

m b

asel

ine

1993

/200

1 to

firs

t ne

urop

sych

olog

ical

as

sess

men

t 7.

2 (2

.4)

year

s; fr

om fi

rst

to s

econ

d

neur

opsy

chol

ogic

al

asse

ssm

ent

6 (2

.0) y

ears

Sm

okin

g, B

MI,

phy

sica

l act

ivity

, die

t,

tota

l cho

lest

erol

, sys

tolic

and

dia

stol

ic

BP,

fast

ing

pla

sma

gluc

ose.

Up

psa

la L

ongi

tud

inal

S

tud

y of

Ad

ult

Men

98P

opul

atio

n co

hort

, Sw

eden

, all

men

bor

n 19

20–1

924

invi

ted

(age

d 5

0 ye

ars)

, 232

2 p

artic

ipat

ed a

t b

asel

ine,

117

4 w

ith n

o d

emen

tia in

clud

ed in

follo

w-u

p

Bas

elin

e 49

.6 (0

.6),

follo

w-u

p 7

1.0

(0.6

)M

idlif

e0

20 y

ears

Sys

tolic

BP,

BM

I, fa

stin

g p

lasm

a gl

ucos

e, s

erum

cho

lest

erol

, sm

okin

g st

atus

, ed

ucat

ion

leve

l, ap

olip

opro

tein

Ɛ4

.

Was

hing

ton

Hei

ghts

co

hort

89Lo

ngitu

din

al c

ohor

t of

Med

icar

e re

cip

ient

s re

sid

ing

in N

orth

ern

Man

hatt

an

(Was

hing

ton

Hei

ghts

), U

SA

. Sam

ple

n=

1138

76.2

(SD

2.9

)La

te-l

ife70

1992

–199

4–20

03. M

ean

5.5

(SD

3.2

) yea

rsH

yper

tens

ion,

hea

rt d

isea

se, d

iab

etes

, sm

okin

g, h

igh-

den

sity

lip

opro

tein

(H

DL)

, low

-den

sity

lip

opro

tein

(LD

L)

chol

este

rol a

nd t

rigly

cerid

es, B

MI,

smok

ing

and

hom

ocys

tein

e le

vels

(the

la

ter

excl

uded

as

dat

a no

t av

aila

ble

for

the

who

le s

amp

le).

Was

hing

ton

Hei

ghts

co

hort

97Lo

ngitu

din

al c

ohor

t of

Med

icar

e re

cip

ient

s re

sid

ing

in N

orth

ern

Man

hatt

an

(Was

hing

ton

Hei

ghts

), U

SA

. Sam

ple

n=

1880

77.2

(SD

6.6

)La

te-l

ife69

1992

–199

4–20

06P

hysi

cal a

ctiv

ity, d

iet.

Was

hing

ton

Hei

ghts

co

hort

94Lo

ngitu

din

al c

ohor

t of

Med

icar

e re

cip

ient

s re

sid

ing

in N

orth

ern

Man

hatt

an

(Was

hing

ton

Hei

ghts

), U

SA

. Sam

ple

n=

4077

Whi

te 7

8.0

(7.4

), b

lack

77

.8 (7

.1),

His

pan

ic 7

6.6

(6.7

)

Late

-life

Whi

te 6

4,

bla

ck 7

1,

His

pan

ic

69

Med

ian

5, 4

1. F

rom

199

2 to

199

9 fo

llow

ed e

very

18

–30

mon

ths

Ind

ivid

ual r

isk

fact

ors

not

exp

licitl

y st

ated

in t

his

pub

licat

ion

but

sta

tes

that

it w

as t

he s

ame

as t

he s

core

use

d

by

Luch

sing

er e

t al

.89 H

yper

tens

ion,

he

art

dis

ease

, dia

bet

es, s

mok

ing.

HD

L,

LDL

chol

este

rol,

trig

lyce

rides

, BM

I, sm

okin

g an

d h

omoc

yste

ine

leve

ls.

Tab

le 1

C

ontin

ued

Con

tinue

d

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 8: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

8 Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

behaviours90 91 and better cognitive outcomes at follow-up. For the remaining studies, that is, those that reported a more mixed relationship between risk factor exposure and increased risk, the Personality and Total Health study found that only reaction time showed a relationship between risk factors and cognitive outcomes108; for the Schneider et al analyses of the Washington Heights study, risk factors were only associated with a small attenuation in decline in memory measures in black participants94 and in the Cache Country study, the unhealthy behaviours plus religious belief cluster showed an increased risk of dementia, while the unhealthy behaviour, non-religious group and the healthy behaviour groups did not.95 In addi-tion to the Cache County study, two further studies exam-ined the relationship between groups of co-occurring risk factors. The Supplementation en vitamines et mineraux antioxy dants study study reported that their unhealthy lifestyle latent factor was associated with poorer memory but not with executive function and that the main drivers for this association were low fruit and vegetable consump-tion and low physical activity.105 The Betula Study found that varying clusters of health components (metabolic, glycaemic, lipid, thyroid, inflammatory and nutritional clusters) had varying relationships with differing cogni-tive abilities with the metabolic component showing the strongest relationships99 (table 3).

Finally, results were essentially consistent across the studies with more than one publication. The Whitehall study found a relationship between increased risk factor exposure and different measures of cognitive decline using both latent growth curve106 and logistic regression analyses107; the Washington Heights study reported an increased risk of incident AD89 with greater numbers of risk factors and a lower risk of incident AD with greater health behaviours (diet and physical activity).97

Six studies provided various risk ratios for the impact of one, two or three or more risk factors; five for incident dementia88 93 98 100 101 (figure 2 and online supplementary text 2 show results of each meta-analysis) and three for AD (online supplementary figure 1).89 98 100 Forest plots of these showed a clear dose response such that higher numbers of risk factors were associated with an increased risk. Based on the rare disease assumption,110 RRs, ORs and HRs were combined in two separate meta-analyses, one for dementia and the other for AD, yielding pooled ratios for presence of one, two and three or more risk factors compared with no risk factors. A fixed effects meta-analysis was used because the number of studies was small preventing a good estimate of the between study variance, however for comparability results are also reported for a random effects model. See online supplementary text 2 for details of the meta-analyses. For dementia outcomes fixed effect pooled risk ratios for one risk factor were 1.2 (95% CI 1.0 to 1.4), for two risk factors 1.7 (95% CI 1.4 to 1.9) and for three or more risk factors 2.2 (95% CI 1.8 to 2.7).88 93 98 100 101 Results for the random effects model did not differ. Heterogeneity was low and there was no evidence of publication bias (online S

tud

y na

me

Po

pul

atio

n

Ag

e at

bas

elin

eM

ean

(SD

) unl

ess

oth

erw

ise

stat

ed

Youn

g a

dul

t lif

e, m

idlif

e o

r la

te-l

ife

bas

elin

eP

er c

ent

fem

ale

Follo

w-u

pM

ean

(SD

) unl

ess

oth

erw

ise

stat

edR

isk

fact

or

dat

a

Whi

teha

ll II

stud

y106

Lond

on, U

K-b

ased

civ

il se

rvan

t of

fice

staf

f fr

om 2

0 d

epar

tmen

ts. S

amp

le n

=64

73N

ever

sm

oker

s gr

oup

55

.5 (6

.1),

ex-s

mok

er

grou

p 5

6.3

(6.0

), cu

rren

t sm

oker

gro

up 5

5.1

(5.8

) R

ange

45–

69

Mid

life

2819

97–1

999–

2007

–200

9.

10 y

ears

Dat

a on

cig

aret

te s

mok

ing

and

alc

ohol

co

nsum

ptio

n fr

om 1

985

to 1

998

(orig

inal

stu

dy

recr

uitm

ent),

199

1–19

93,

1997

–199

9, 2

002–

2004

, 200

7–20

09.

Whi

teha

ll II

stud

y107

Lond

on, U

K-b

ased

civ

il se

rvan

t of

fice

staf

f fr

om 2

0 d

epar

tmen

ts. S

amp

le n

=51

23B

asel

ine

mea

n 44

(6.0

). Fo

llow

-up

mea

n 61

.1 (6

.0)

Mid

life

2819

85–1

988–

2002

–200

4.

~17

yea

rsS

mok

ing,

alc

ohol

inta

ke, p

hysi

cal

activ

ity, d

ieta

ry b

ehav

iour

. Hea

lth

beh

avio

ur d

ata

colle

cted

at

pha

se I

1985

–198

8, p

hase

V 1

997–

1999

and

p

hase

IX 2

002–

2004

.

Tab

le 1

C

ontin

ued

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 9: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

9Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

Tab

le 2

O

utco

mes

and

ana

lysi

s m

etho

ds

for

22 s

tud

ies

incl

uded

in s

yste

mat

ic r

evie

w

Stu

dy

Co

gni

tive

out

com

esR

isk

fact

or

agg

reg

atio

n, c

lass

ifica

tio

n o

f ri

sk f

acto

r ex

po

sure

mea

sure

Ana

lysi

s m

etho

ds

Bet

ula

Stu

dy

9911

ep

isod

ic r

ecal

l tas

ks, 3

rec

ogni

tion

task

s, 4

flue

ncy

task

s (2

sem

antic

, 2

pho

nem

ic) a

nd a

sp

atia

l ab

ility

tas

kC

omp

onen

t sc

ores

. Cog

nitiv

e sc

ores

co

nver

ted

to

z sc

ores

and

com

bin

ed fo

r ea

ch c

ogni

tive

dom

ain

Six

fact

ors

wer

e ob

tain

ed fr

om t

he 1

4 he

alth

var

iab

les

usin

g p

rinci

pal

com

pon

ents

an

alys

es. M

etab

olic

com

pon

ent

(sys

tolic

blo

od p

ress

ure

(BP

), d

iast

olic

BP

and

bod

y m

ass

ind

ex (B

MI)

Gly

caem

ic c

omp

onen

t (g

luco

se, h

aem

oglo

bin

A1c

)Li

pid

com

pon

ent

(trig

lyce

rides

, tot

al c

hole

ster

ol)

Infla

mm

ator

y co

mp

onen

t (e

ryth

rocy

te s

edim

enta

tion

rate

, hae

mog

lob

in, a

lbum

in)

Nut

ritio

nal c

omp

onen

t (B

12, f

olat

e)Th

yroi

d c

omp

onen

t (th

yroi

d-s

timul

atin

g ho

rmon

e, t

hyro

xine

)R

esid

ual c

hang

e sc

ores

com

put

ed fo

r he

alth

and

cog

nitiv

e ch

ange

bet

wee

n w

aves

1 a

nd 2

an

d c

ogni

tive

chan

ge b

etw

een

wav

es 1

and

3 a

nd w

aves

2 a

nd 3

Thre

e se

ts o

f lon

gitu

din

al a

naly

sis:

1. H

ealth

fact

ors

at b

asel

ine

pre

dic

ting

cogn

itive

cha

nge

bet

wee

n w

aves

1 a

nd 3

.2.

Cha

nge

in h

ealth

fact

ors

bet

wee

n w

aves

1 a

nd 2

as

soci

ated

with

cog

nitiv

e ch

ange

bet

wee

n w

aves

1 a

nd

2. 3. C

hang

e in

hea

lth fa

ctor

s b

etw

een

wav

es 1

and

2

pre

dic

ting

cogn

itive

cha

nge

bet

wee

n w

aves

2 a

nd 3

.

Cac

he C

ount

y S

tud

y 95

Inci

den

t d

emen

tia(D

iagn

ostic

Sta

tistic

al M

anua

l IIIR

(D

SM

IIIR

)) an

d A

lzhe

imer

’s d

isea

se (A

D)

(Nat

iona

l Ins

titut

e of

Neu

rolo

gica

l and

C

omm

unic

ativ

e D

isor

der

s an

d S

trok

e an

d t

he A

lzhe

imer

’s D

isea

se a

nd R

elat

ed

Dis

ord

ers

Ass

ocia

tion

(NIN

CD

S-A

DR

DA

))

Late

nt c

lass

ana

lysi

s to

iden

tify

pat

tern

s in

the

six

life

styl

e b

ehav

iour

sR

elat

ions

hip

bet

wee

n la

tent

cla

sses

and

inci

den

t d

emen

tia e

xam

ined

by

pro

por

tiona

l haz

ard

s re

gres

sion

us

ing

year

s to

dem

entia

sta

rtin

g at

age

65

year

s.Fo

ur li

fest

yle

clas

ses

wer

e id

entifi

ed.

Car

dio

vasc

ular

Ris

k Fa

ctor

s, A

gein

g an

d

Dem

entia

stu

dy10

1

Inci

den

t d

emen

tia (D

SM

IV) a

nd A

D

(NIN

CD

S-A

DR

DA

)D

icho

tom

ised

the

n su

mm

ed t

hree

mid

life

risk

fact

ors

(from

sur

veys

in 7

2, 7

7, 8

2 an

d 8

7)Lo

gist

ic r

egre

ssio

n co

mp

arin

g th

ose

with

1, 2

or

3 ris

k fa

ctor

s w

ith t

hose

with

no

risk

fact

ors

for

inci

den

t d

emen

tia a

t re

-exa

min

atio

n as

the

out

com

e. W

ere

ther

e >

3?

Cor

onar

y A

rter

y R

isk

Dev

elop

men

t in

You

ng

Ad

ults

90

Dig

it S

ymb

ol S

ubst

itutio

n Te

st, S

troo

p t

est,

R

ey A

udito

ry V

erb

al L

earn

ing

Test

(lon

g d

elay

free

rec

all)

Sev

en h

ealth

fact

ors

wer

e ca

tego

rised

as

idea

l, in

term

edia

te o

r p

oor

heat

h us

ing

a sl

ight

ly

mod

ified

ver

sion

of t

he A

mer

ican

Hea

rt A

ssoc

iatio

n (A

HA

) crit

eria

(onl

ine

sup

ple

men

t te

xt 1

). Th

e to

tal n

umb

er o

f hea

lth c

omp

onen

ts a

t id

eal l

evel

s w

as c

alcu

late

d b

ased

on

the

aver

age

leve

l of e

ach

acro

ss t

he 0

, 7 a

nd 2

5 ye

ar e

xam

inat

ions

as

wel

l as

the

num

ber

p

r ese

nt a

t ye

ars

0 an

d 2

5. T

he s

core

ran

ged

from

0 (n

one

at id

eal l

evel

s) t

o 7

(all

idea

l).

Als

o us

ed a

cut

poi

nt o

f ≥5

idea

l hea

lth m

etric

s at

0, 1

, 2 o

r al

l 3 e

xam

inat

ions

and

a s

core

of

1–1

4 w

here

poo

r he

alth

sco

red

0, i

nter

med

iate

hea

lth 1

and

idea

l hea

lth 2

als

o b

ased

on

aver

age

exp

osur

e

Mul

tivar

iab

le li

near

reg

ress

ion

was

use

d t

o es

timat

e th

e as

soci

atio

n b

etw

een

heal

th c

omp

onen

ts a

nd e

ach

cogn

itive

func

tion.

Mul

tiple

imp

utat

ion

used

to

imp

ute

mis

sing

val

ues

usin

g d

ata

from

all

eigh

t ex

amin

atio

ns a

nd r

esul

ting

in

com

ple

te y

ear

0, 7

and

25

dat

a fo

r 29

32 in

div

idua

ls.

Ad

diti

onal

sen

sitiv

ity a

naly

sis

per

form

ed o

n 17

53

par

ticip

ants

who

had

com

ple

te in

form

atio

n on

all

heal

th

beh

avio

urs

and

fact

ors

acro

ss a

ll th

ree

exam

inat

ions

.

Fram

ingh

am S

tud

y 96

Kap

lan

Alb

ert

neur

opsy

chol

ogic

al

bat

tery

—in

clud

es lo

gica

l mem

ory,

vis

ual

rep

rod

uctio

n, p

aire

d a

ssoc

iate

s, d

igit

span

fo

rwar

ds

and

bac

kwar

ds,

sim

ilarit

ies,

wor

d

fluen

cy, d

elay

ed m

emor

y

Sco

re u

sed

as

the

ind

epen

den

t va

riab

le, 0

for

neith

er r

isk

fact

or, 1

for

each

ris

k fa

ctor

and

2

for

pre

senc

e of

bot

h ris

k fa

ctor

sLi

near

reg

ress

ion

to e

xam

ine

the

com

bin

ed e

ffect

of

obes

ity a

nd h

yper

tens

ion

on c

ogni

tive

mea

sure

s.

Hon

olul

u A

sia

Age

ing

Stu

dy88

Inci

den

t d

emen

tia (D

SM

IIIR

), A

D (N

INC

DS

-A

DR

DA

), va

scul

ar d

emen

tia (c

riter

ia

pro

vid

ed b

y th

e C

alifo

rnia

Alz

heim

er’s

D

isea

se a

nd t

reat

men

t ce

ntre

s)

Ris

k fa

ctor

mea

sure

s co

nver

ted

to

z sc

ores

. Tho

se w

ith s

kew

ed d

istr

ibut

ions

wer

e tr

ansf

orm

ed p

rior

to c

onve

rsio

n an

d t

he r

elat

ions

hip

s w

ith t

he o

utco

me

chec

ked

to

ensu

re

they

wer

e lin

ear.

Z s

core

s w

ere

sum

med

ove

r th

e se

ven

risk

fact

ors

thus

ens

urin

g a

cont

ribut

ion

from

eac

h ris

k fa

ctor

Logi

stic

reg

ress

ion

used

to

eval

uate

the

rel

atio

nshi

p

bet

wee

n th

e z

scor

e su

m a

nd d

emen

tia o

utco

me.

R

esul

ts a

re r

epor

ted

as

rela

tive

risks

(RR

) und

er t

he

rare

dis

ease

ass

ump

tion

that

OR

can

be

cons

ider

ed a

n ap

pro

xim

atio

n of

RR

.

Hoo

rn S

tud

y102

Neu

rop

sych

olog

ical

bat

tery

incl

udin

g m

emor

y, w

orki

ng m

emor

y, im

med

iate

m

emor

y, d

elay

ed m

emor

y, a

tten

tion

and

ex

ecut

ive

func

tion,

pro

cess

ing

spee

d,

visu

ocon

stru

ctio

n, la

ngua

ge a

nd a

bst

ract

re

ason

ing

test

z s

core

sZ

sco

res

wer

e ad

just

ed o

n an

ind

ivid

ual

bas

is fo

r ag

e, s

ex, I

Q Im

pai

rmen

t d

efine

d

as z

sco

re≤1

.5

Wei

ghte

d r

isk

scor

e in

clud

ed a

dd

ition

al w

eigh

ts fo

r ol

der

age

, low

er e

duc

atio

n an

d s

ex. T

he

four

mod

ifiab

le r

isks

wer

e sc

ored

as

0 or

1 a

nd s

umm

ed. S

ee o

nlin

e su

pp

lem

enta

ry t

able

1

for

det

ails

of c

ut p

oint

s.

Logi

stic

reg

ress

ion

to e

valu

ate

risk

of im

pai

rmen

t.

Rea

naly

sed

exc

lud

ing

non-

mod

ifiab

le r

isk

fact

ors

from

th

e sc

ore.

Con

tinue

d

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 10: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

10 Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

Stu

dy

Co

gni

tive

out

com

esR

isk

fact

or

agg

reg

atio

n, c

lass

ifica

tio

n o

f ri

sk f

acto

r ex

po

sure

mea

sure

Ana

lysi

s m

etho

ds

Inte

rven

tion

pro

ject

on

cer

ebro

vasc

ular

d

isea

se a

nd d

emen

tia

in t

he d

istr

ict

of

Eb

ersb

erg10

4

Dem

entia

dia

gnos

es r

etrie

ved

from

hea

lth

insu

ranc

e cl

aim

s d

ata,

dia

gnos

is w

as

req

uire

d t

o b

e re

cord

ed o

n at

leas

t tw

o q

uart

erly

rec

ord

s

Six

ris

k fa

ctor

s sc

ored

as

idea

l 2 p

oint

s, m

oder

ate

1 p

oint

and

poo

r 0

poi

nts

Pro

por

tiona

l haz

ard

reg

ress

ion

used

to

eval

uate

the

re

latio

nshi

p b

etw

een

bas

elin

e sc

ore

and

inci

den

t d

emen

tia. T

ime

from

bas

elin

e un

til d

ate

of d

iagn

osis

in

the

heal

th in

sura

nce

reco

rds.

Kai

ser

Per

man

ente

M

edic

al C

are

Pro

gram

93

Dem

entia

dia

gnos

es e

nter

ed b

y tr

eatin

g p

hysi

cian

. Dem

entia

asc

erta

inm

ent

from

19

94 t

o 20

03

A c

omp

osite

car

dio

vasc

ular

ris

k sc

ore

was

cre

ated

usi

ng m

idlif

e hy

per

tens

ion,

dia

bet

es,

high

cho

lest

erol

, sm

okin

g. E

ach

risk

fact

or s

core

d 1

if p

rese

nt a

nd s

umm

ed t

o a

max

imum

of

4

Pro

por

tiona

l haz

ard

reg

ress

ion

used

to

exam

ine

the

rela

tions

hip

bet

wee

n b

asel

ine

risk

fact

ors

and

dem

entia

ou

tcom

es.

Kun

gsho

lmen

p

roje

ct10

0D

emen

tia a

sses

smen

t at

eac

h vi

sit,

DS

MIII

. D

iagn

oses

: dem

entia

and

AD

Cre

ated

vas

cula

r ris

k p

rofil

es b

y sc

orin

g va

scul

ar r

isk

fact

ors.

Ove

rall

vasc

ular

ris

k p

rofil

e in

clud

ed h

igh

syst

olic

and

low

dia

stol

ic B

P, lo

w p

ulse

pre

ssur

e, d

iab

etes

or

pre

-dia

bet

es,

prio

r st

roke

and

dia

gnos

is o

f hea

rt fa

ilure

. Ath

eros

cler

otic

ris

k p

rofil

e in

clud

ed h

igh

syst

olic

B

P, d

iab

etes

or

pre

-dia

bet

es a

nd s

trok

e; h

ypop

erfu

sion

ris

k p

rofil

e in

clud

ed lo

w d

iast

olic

B

P, lo

w p

ulse

pre

ssur

e an

d h

eart

failu

re

Cox

pro

por

tiona

l haz

ard

mod

els

used

to

exam

ine

vario

us v

ascu

lar

pro

files

in a

ssoc

iatio

n w

ith r

isk

of

dem

entia

and

AD

.

Maa

stric

ht A

gein

g S

tud

y103

Dem

entia

dia

gnos

is b

y co

nsen

sus

com

mitt

ee (n

euro

psy

chol

ogis

t an

d

neur

opsy

chia

tris

t) b

ased

on

DS

MIV

. C

ogni

tive

test

ing,

ver

bal

mem

ory,

exe

cutiv

e fu

nctio

n, p

roce

ssin

g sp

eed

. Inc

iden

t co

gniti

ve im

pai

rmen

t d

efine

d a

s <

1.5

SD

b

elow

the

mea

n on

any

of t

he c

ogni

tive

test

s at

6-y

ear

or 1

2-ye

ar a

sses

smen

ts

Ris

k sc

ore

crea

ted

by

taki

ng t

he n

atur

al lo

garit

hm o

f the

RR

for

each

ris

k fa

ctor

, st

and

ard

ised

by

taki

ng t

he r

esul

t fr

om t

he lo

wes

t na

tura

l log

of t

he R

Rs

as a

ref

eren

ce v

alue

an

d d

ivid

ing

the

othe

r va

lues

by

this

val

ue. T

hen

sum

min

g th

e re

sulti

ng s

core

s as

sign

ed t

o ea

ch r

isk

fact

or t

o cr

eate

a r

isk

scor

e

Pro

por

tiona

l haz

ard

reg

ress

ion

used

to

exam

ine

rela

tions

hip

s b

etw

een

risk

scor

e an

d in

cid

ent

cogn

itive

d

eclin

e an

d d

emen

tia. L

inea

r m

ixed

mod

els

used

to

exam

ine

rela

tions

hip

s b

etw

een

risk

scor

e an

d c

ogni

tive

chan

ge.

Nor

ther

n M

anha

ttan

S

tud

y91N

euro

psy

chol

ogic

al b

atte

ry c

omb

ined

into

z

scor

es fo

r ep

isod

ic m

emor

y, p

roce

ssin

g sp

eed

, sem

antic

mem

ory

and

exe

cutiv

e fu

nctio

n (b

ased

on

exp

lora

tory

fact

or

anal

ysis

of t

he fu

ll b

atte

ry a

nd p

rior

wor

k)Fo

r ch

ange

in c

ogni

tive

scor

e, c

omp

osite

sc

ores

in t

he fo

ur c

ogni

tive

dom

ains

wer

e ca

lcul

ated

usi

ng r

egre

ssio

n-b

ased

rel

iab

le

chan

ge in

dic

es o

f the

cor

resp

ond

ing

ind

ivid

ual t

est

adju

sted

for

age,

ed

ucat

ion

year

s an

d t

he t

ime

bet

wee

n th

e tw

o te

sts

The

seve

n he

alth

fact

ors

wer

e ca

tego

rised

as

idea

l or

not

idea

l bas

ed o

n th

e A

HA

d

efini

tions

and

sum

med

to

reac

h a

scor

e b

etw

een

0 an

d 7

Mul

tivar

iab

le li

near

reg

ress

ion

mod

els

used

to

exam

ine

the

asso

ciat

ion

bet

wee

n b

asel

ine

heal

th fa

ctor

sco

re

and

z s

core

s at

neu

rop

sych

olog

ical

tes

ting

wav

e 1

and

cha

nge

in z

sco

res

bet

wee

n ne

urop

sych

olog

ical

te

stin

g b

etw

een

wav

es 1

and

2. S

core

s w

ere

exam

ined

co

ntin

uous

ly a

nd d

ivid

ed in

to fo

ur c

ateg

orie

s: 0

–1

(refe

renc

e), 2

, 3, 4

–7 h

ealth

fact

ors.

Per

sona

lity

and

Tot

al

Hea

lth, P

ath

thro

ugh

life

stud

y108

Neu

rop

sych

olog

ical

bat

tery

incl

udin

g m

easu

res

of v

erb

al a

bili

ty, p

roce

ssin

g sp

eed

, del

ayed

and

imm

edia

te r

ecal

l, w

orki

ng m

emor

y an

d r

eact

ion

time.

A

glob

al s

core

was

cal

cula

ted

by

sum

min

g st

and

ard

ised

tes

t sc

ores

for

the

six

ind

ivid

ual i

tem

s an

d d

ivid

ing

by

6

A r

isk

scor

e (P

ATH

risk)

was

con

stru

cted

from

six

ind

ivid

ual r

isk

fact

ors

(eac

h ris

k fa

ctor

co

ntrib

uted

one

poi

nt t

o a

tota

l of s

ix)

Mul

tivar

iab

le m

odel

s w

ere

used

to

exam

ine

the

rela

tions

hip

bet

wee

n b

asel

ine

PATH

risk

scor

e an

d

cogn

itive

func

tion

acro

ss a

ll th

ree

wav

es o

f the

st

udy.

Tw

o m

ain

mod

els

wer

e us

ed, t

he fi

rst

incl

uded

ge

nder

, tim

e, P

ATH

risk*

time

and

PAT

Hris

k. T

he s

econ

d

incl

uded

gen

der

, tim

e, e

duc

atio

n, t

ime*

PATH

risk

and

ed

ucat

ion*

PATH

risk.

Ind

ivid

ual r

isk

fact

ors

wer

e al

so

exam

ined

.

San

Lui

s Va

lley

Hea

lth

ad A

ging

Stu

dy

92In

cid

ent

cogn

itive

dec

line

defi

ned

as

a fa

ll in

Min

i-M

enta

l Sta

te E

xam

inat

ion

(MM

SE

)≥2

poi

nts

at fo

llow

-up

. Inc

iden

t ex

ecut

ive

dys

func

tion

defi

ned

as

a d

eclin

e≥0.

5 of

SD

(2.5

–3 p

oint

s) in

the

ex

ecut

ive

cont

rol b

ehav

iour

al d

ysco

ntro

l sc

ale

The

thre

e in

div

idua

l ris

k fa

ctor

s w

ere

dic

hoto

mis

ed a

s p

rese

nt/a

bse

nt a

nd s

umm

ed t

o cr

eate

a s

core

Logi

stic

reg

ress

ion

was

use

d t

o ex

amin

e th

e re

latio

nshi

p

bet

wee

n ris

k fa

ctor

s an

d c

ogni

tive

dec

line.

Tab

le 2

C

ontin

ued

Con

tinue

d

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 11: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

11Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

Stu

dy

Co

gni

tive

out

com

esR

isk

fact

or

agg

reg

atio

n, c

lass

ifica

tio

n o

f ri

sk f

acto

r ex

po

sure

mea

sure

Ana

lysi

s m

etho

ds

Sup

ple

men

tatio

n en

vi

tam

ines

et

min

erau

x an

tioxy

dan

ts s

tud

y105

Sev

eral

sta

ndar

d n

euro

psy

chol

ogic

al

test

s ad

min

iste

red

and

tw

o su

mm

ary

mea

sure

s b

ased

on

exec

utiv

e fu

nctio

n an

d

verb

al m

emor

y p

lus

an o

vera

ll co

mp

osite

co

gniti

ve s

core

der

ived

To id

entif

y la

tent

unh

ealth

y lif

esty

le fa

ctor

s re

late

d t

o co

gniti

on u

sed

str

uctu

ral e

qua

tion

mod

els

Use

d a

naly

sis

of c

ovar

ianc

e to

est

imat

e as

soci

atio

ns

bet

wee

n in

div

idua

l and

com

bin

ed u

nhea

lthy

beh

avio

urs

(as

cate

gorie

s an

d o

n a

cont

inuo

us s

cale

). A

lso

crea

ted

an

d m

odel

led

a s

core

of 7

dic

hoto

mis

ed u

nhea

lthy

varia

ble

s.

Suw

on L

ongi

tud

inal

A

gein

g S

tud

y109

Kor

ean

MM

SE

. Cha

nge

over

follo

w-u

pD

icho

tom

ised

the

n su

mm

ed p

ositi

ve fo

ur h

ealth

beh

avio

urs

to fo

rm a

pro

tect

ive

scor

eU

sed

mul

tivar

iab

le li

near

reg

ress

ion

to e

xam

ine

influ

ence

of

ris

k/p

rote

ctiv

e fa

ctor

s on

cog

nitiv

e ch

ange

.

Up

psa

la L

ongi

tud

inal

S

tud

y of

Ad

ult

Men

98E

xper

t p

anel

rev

iew

of m

edic

al r

ecor

ds

up t

o 1

Janu

ary

2010

. Dem

entia

(DS

MIV

cr

iteria

), A

D (N

INC

DS

-AD

RD

A),

vasc

ular

d

emen

tia (A

lzhe

imer

’s D

isea

se D

iagn

osis

an

d T

reat

men

t C

entr

e, m

ixed

dem

entia

(AD

an

d c

ereb

rova

scul

ar c

ontr

ibut

ion)

Five

ris

k fa

ctor

s sc

ored

1 if

pre

sent

(sm

okin

g) o

r ab

ove

a d

efine

d c

ut-o

ff fo

r B

MI,

syst

olic

B

P, fa

stin

g p

lasm

a gl

ucos

e, s

erum

cho

lest

erol

, max

imum

sco

re 5

Cox

pro

por

tiona

l haz

ard

reg

ress

ion

used

to

eval

uate

ris

k of

dem

entia

cal

cula

ted

for

ind

ivid

ual a

nd s

umm

ed r

isk

fact

ors

pre

sent

at

age

50 a

nd a

t ag

e 70

yea

rs.

Was

hing

ton

Hei

ghts

co

hort

89C

onse

nsus

con

fere

nce

to d

iagn

ose

dem

entia

. Dia

gnos

is o

f AD

bas

ed o

n N

INC

DS

-AD

RD

A

Four

ris

k fa

ctor

s w

ere

dic

hoto

mis

ed a

nd t

reat

ed a

s tim

e d

epen

den

t co

varia

tes

whe

re

follo

w-u

p d

ate

was

dat

e of

dia

gnos

is. M

edia

n an

d q

uart

iles

used

for

BM

I and

low

-den

sity

lip

opro

tein

(LD

L) c

hole

ster

ol. R

etai

ned

var

iab

les

wer

e su

mm

ed t

o cr

eate

a s

core

. Dat

e of

ev

ent

was

age

of o

nset

of d

emen

tia

Pro

por

tiona

l haz

ard

s re

gres

sion

. Ris

k fa

ctor

s en

tere

d

into

uni

varia

te a

naly

ses,

tho

se a

chie

ving

sig

nific

ance

va

lues

of ≤

0.1

wer

e re

tain

ed in

mul

tifac

toria

l reg

ress

ion.

Was

hing

ton

Hei

ghts

co

hort

97C

onse

nsus

con

fere

nce

to d

iagn

ose

dem

entia

bas

ed o

n D

SM

IIIR

. Dia

gnos

is o

f A

D b

ased

on

NIN

CD

S-A

DR

DA

Die

t sc

ore

non-

bin

ary,

ran

ge 0

–9, h

ighe

r is

bet

ter,

phy

sica

l act

ivity

dic

hoto

mis

ed in

to lo

w

and

hig

h. R

isk

eval

uate

d fo

r co

mb

inat

ions

of p

hysi

cal a

ctiv

ity a

nd d

iet

scor

e.P

rop

ortio

nal h

azar

d r

egre

ssio

n tim

e to

AD

(firs

t vi

sit

with

A

D d

iagn

osis

).

Was

hing

ton

Hei

ghts

co

hort

94A

glo

bal

com

pos

ite, e

xecu

tive

func

tion

com

pos

ite a

nd m

emor

y co

mp

osite

sc

ore

from

fact

or a

naly

sis

of d

ata

from

a

neur

opsy

chol

ogic

al b

atte

ry

Four

ris

k fa

ctor

s w

ere

dic

hoto

mis

ed a

nd t

reat

ed a

s tim

e-d

epen

den

t co

varia

tes

whe

re

follo

w-u

p d

ate

was

dat

e of

dia

gnos

is. M

edia

n an

d q

uart

iles

used

for

BM

I and

LD

L ch

oles

tero

l. R

etai

ned

var

iab

les

wer

e su

mm

ed t

o cr

eate

a s

core

. Dat

e of

eve

nt w

as a

ge o

f on

set

of d

emen

tia

Mul

tiple

gro

up p

aral

lel p

roce

ss r

and

om e

ffect

s re

gres

sion

usi

ng d

ata

from

all

follo

w-u

p e

valu

atio

ns

adju

sted

for

rete

st e

ffect

s.

Whi

teha

ll II

stud

y106

Glo

bal

cog

nitiv

e sc

ore

com

bin

ing

z sc

ores

from

tes

ts o

f ind

uctiv

e re

ason

ing,

sh

ort-

term

ver

bal

mem

ory,

ver

bal

flue

ncy.

C

ogni

tive

func

tion

asse

ssed

at

bas

elin

e, in

20

02–2

004

and

200

7–20

09

Exa

min

ed a

ssoc

iatio

n b

etw

een

smok

ers,

nev

er a

nd e

x-sm

oker

s, a

bst

inen

t, m

oder

ate

and

he

avy

alco

hol u

sers

and

the

ir in

tera

ctio

ns a

nd g

lob

al c

ogni

tion

scor

eLa

tent

gro

wth

cur

ve m

odel

s (a

llow

ing

corr

elat

ion

bet

wee

n re

pea

ted

mea

sure

s) t

o ex

amin

e th

e as

soci

atio

n b

etw

een

smok

ers,

nev

er a

nd e

x-sm

oker

s, a

bst

inen

t,

mod

erat

e an

d h

eavy

alc

ohol

use

rs a

nd t

heir

inte

ract

ions

an

d g

lob

al c

ogni

tion

scor

e. S

ensi

tivity

ana

lyse

s:

anal

yses

rep

eate

d fo

r th

ose

with

an

MM

SE

≥24

in 2

002–

2004

and

200

7–20

09.

Whi

teha

ll II

stud

y107

Mem

ory

an e

xecu

tive

func

tion.

The

la

tter

der

ived

from

a c

omp

osite

of t

hree

ne

urop

sych

olog

ical

tes

ts. M

emor

y w

as

asse

ssed

usi

ng a

ver

bal

mem

ory

free

rec

all

test

. Poo

r ex

ecut

ive

func

tion

defi

ned

as

the

low

est

sex

spec

ific

qui

ntile

. Poo

r m

emor

y as

<5/

20 w

ord

s co

rrec

tly r

ecal

led

Sum

med

(dic

hoto

mis

ed) s

core

s of

4 h

ealth

beh

avio

urs

at e

ach

pha

se a

nd a

cros

s al

l thr

ee

pha

ses

Uni

varia

te lo

gist

ic r

egre

ssio

n re

latin

g in

div

idua

l hea

lth

beh

avio

urs

to c

ogni

tive

outc

omes

at

pha

se I,

V a

nd V

II (c

ross

-sec

tiona

l) fo

llow

ed b

y su

mm

ed (d

icho

tom

ised

) sc

ores

of h

ealth

beh

avio

urs

at e

ach

pha

se a

nd a

cros

s al

l th

ree

pha

ses.

Tab

le 2

C

ontin

ued

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 12: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

12 Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

Tab

le 3

R

esul

ts fo

r 22

stu

die

s in

clud

ed in

sys

tem

atic

rev

iew

Stu

dy

Res

ult

Co

vari

ates

ad

just

ed f

or

Ris

k fa

cto

r ha

ndlin

g

Bet

ula

Stu

dy99

1: H

ealth

fact

ors

at b

asel

ine

pre

dic

ted

cog

nitiv

e ch

ange

bet

wee

n w

aves

1 a

nd 3

Met

abol

ic c

omp

onen

t p

red

icte

d fa

ll in

per

form

ance

on

reca

ll, r

ecog

nitio

n, s

pat

ial a

bili

ty a

nd p

hone

mic

flue

ncy

(P<

0.00

1 fo

r al

l).G

lyca

emic

com

pon

ent

pre

dic

ted

fall

in p

erfo

rman

ce o

n re

call

(P<

0.00

1), r

ecog

nitio

n (P

<0.

01),

spat

ial a

bili

ty (P

<0.

01),

pho

nem

ic fl

uenc

y (P

<0.

001)

.Li

pid

com

pon

ent

pre

dic

ted

fall

in p

erfo

rman

ce o

n re

call

(P<

0.00

1), r

ecog

nitio

n (P

<0.

01),

spat

ial a

bili

ty (P

<0.

001)

, pho

nem

ic fl

uenc

y (P

<0.

001)

.Th

yroi

d c

omp

onen

t p

red

icte

d fa

ll in

per

form

ance

on

reca

ll (P

<0.

05),

reco

gniti

on (P

<0.

01).

Infla

mm

ator

y co

mp

onen

t p

red

icte

d r

ise

in p

erfo

rman

ce o

n re

call

(P<

0.00

1), s

pat

ial a

bili

ty (P

<0.

001)

, pho

nem

ic fl

uenc

y (P

<0.

01).

Nut

ritio

nal c

omp

onen

t p

red

icte

d r

ise

in p

erfo

rman

ce o

n re

cogn

ition

(P<

0.01

), p

hone

mic

flue

ncy

(P<

0.01

).Th

ere

was

no

rela

tions

hip

bet

wee

n an

y he

alth

com

pon

ent

and

sem

antic

flue

ncy.

2: C

hang

e in

hea

lth fa

ctor

s b

etw

een

wav

es 1

and

2 a

ssoc

iate

d w

ith c

ogni

tive

chan

ge b

etw

een

wav

es 1

and

2.

Gly

caem

ic c

hang

e p

red

icte

d fa

ll in

per

form

ance

on

reco

gniti

on (P

<0.

05),

pho

nem

ic fl

uenc

y (P

<0.

05).

Lip

id c

hang

e p

red

icte

d fa

ll in

sp

atia

l ab

ility

(P<

0.01

).In

flam

mat

ory

chan

ge p

red

icte

d r

ise

in p

erfo

rman

ce o

n re

call

(P<

0.00

1), r

ecog

nitio

n (P

<0.

01),

spat

ial a

bili

ty (P

<0.

001)

.3:

Cha

nge

in h

ealth

fact

ors

bet

wee

n w

aves

1 a

nd 2

pre

dic

ting

cogn

itive

cha

nge

bet

wee

n w

aves

2 a

nd 3

.G

lyca

emic

cha

nge

pre

dic

ted

fall

in p

erfo

rman

ce o

n re

call

(P<

0.05

), re

cogn

ition

(P<

0.01

).N

umer

ical

res

ults

from

eac

h m

odel

are

too

num

erou

s to

incl

ude

here

.99

Not

sta

ted

.C

lust

erin

g: p

rinci

pal

co

mp

onen

ts a

naly

sis.

Cac

he C

ount

y S

tud

y95Fo

ur li

fest

yle

clas

ses

iden

tified

:U

nhea

lthy

relig

ious

(11.

5%)

Unh

ealth

y no

n-re

ligio

us (1

0.5%

)H

ealth

y m

oder

atel

y re

ligio

us (3

8.5%

)H

ealth

y ve

ry r

elig

ious

(39.

5%).

Com

par

ed w

ith u

nhea

lthy

relig

ious

: for

dem

entia

: unh

ealth

y no

n-re

ligio

us H

R 0

.54

(95%

CI 0

.31

to 0

.93)

. Hea

lthy

mod

erat

ely

relig

ious

H

R 0

.56

(95%

CI 0

.38

to 0

.84)

. Hea

lthy

very

rel

igio

us H

R 0

.58

(95%

CI 0

.40

to 0

.84)

. Diff

eren

ce b

etw

een

the

thre

e cl

asse

s ab

ove

is

non-

sign

ifica

nt. R

epor

ted

as

sim

ilar

for

Alz

heim

er’s

dis

ease

(AD

).

Age

, sex

, ed

ucat

ion,

re

crui

tmen

t co

hort

and

ap

olip

opro

tein

(AP

OE

) ε4

stat

us.

Clu

ster

ing:

late

nt c

lass

an

alys

is t

o id

entif

y cl

uste

rs.

Car

dio

vasc

ular

Ris

k Fa

ctor

s, A

gein

g an

d

Dem

entia

stu

dy10

1

20%

had

no

bas

elin

e ris

k fa

ctor

s 41

% h

ad 1

, 32%

had

2, 7

% h

ad 3

bas

elin

e ris

k fa

ctor

s.C

omp

ared

with

tho

se w

ith n

o b

asel

ine

risk

fact

ors:

for

dem

entia

:on

e ris

k fa

ctor

OR

1.3

7 (9

5% C

I 0.4

4:4.

27)

two

risk

fact

ors

OR

3.0

3 (9

5% C

I 1.0

3:8.

89)

thre

e ris

k fa

ctor

s O

R 6

.21

(95%

CI 1

.94:

19.9

2) n

=14

09 in

the

mod

el. R

elat

ions

hip

rep

orte

d t

o b

e si

mila

r fo

r A

D.

Age

, sex

, ed

ucat

ion

and

fo

llow

-up

tim

e.U

nwei

ghte

d r

isk

fact

or

scor

e.

Cor

onar

y A

rter

y R

isk

Dev

elop

men

t in

You

ng

Ad

ults

90

Pre

vale

nce

of m

eetin

g th

e id

eal m

etric

(see

defi

nitio

n in

pre

viou

s co

lum

n) d

ecre

ased

ove

r th

e 25

yea

r fo

llow

-up

for

all f

acto

rs e

xcep

t no

n-sm

okin

g.H

ighe

r sc

ores

of i

dea

l hea

lth c

omp

onen

ts a

t ye

ar 0

and

the

ave

rage

acr

oss

year

s 0,

7, 2

5 w

as a

ssoc

iate

d w

ith b

ette

r p

erfo

rman

ce o

n al

l thr

ee t

ests

. Tre

nd t

ests

for

cogn

itive

per

form

ance

and

incr

easi

ng s

core

sho

w s

igni

fican

t re

sults

for

all t

hree

cog

nitiv

e te

sts

for

heal

th

com

pon

ent

scor

e at

bas

elin

e an

d t

he a

vera

ge a

cros

s th

e st

udy.

Eac

h ad

diti

onal

idea

l hea

lth c

omp

onen

t (a

vera

ge e

xpos

ure)

was

ass

ocia

ted

with

1.3

2 m

ore

sym

bol

s on

the

Dig

it S

ymb

ol S

ubst

itutio

n Te

st (9

5% C

I 0.9

3 to

1.7

1), a

0.7

7 p

oint

low

er in

terf

eren

ce s

core

on

the

Str

oop

tes

t (9

5% C

I −1.

03 t

o 0.

45) a

nd 0

.12

mor

e w

ord

s re

calle

d

on t

he R

ey A

udito

ry V

erb

al L

earn

ing

Test

(95%

CI 0

.04

to 0

.20)

.S

imila

r p

atte

rns

wer

e sh

own

whe

n th

e sc

ore

cut

poi

nt o

f ≥5

was

use

d, t

hat

is, g

reat

er id

eal h

ealth

ass

ocia

ted

with

bet

ter

cogn

itive

p

erfo

rman

ce. U

sing

the

0–1

4 sc

ore

also

res

ulte

d in

a s

imila

r p

atte

rn o

f res

ults

. Sen

sitiv

ity a

naly

sis

usin

g on

ly t

hose

with

com

ple

te d

ata

foun

d s

imila

r re

sults

.

Age

, sex

, rac

e (b

lack

/whi

te),

educ

atio

n, a

lcoh

ol u

se a

nd

stud

y ce

ntre

.

Unw

eigh

ted

ris

k fa

ctor

sc

ore.

Fram

ingh

am S

tud

y96Li

mite

d in

form

atio

n p

rovi

ded

in t

he a

rtic

le. R

esul

ts fo

r th

e sc

orin

g ar

e p

rovi

ded

in fi

gure

1 o

f the

art

icle

. The

figu

re s

how

s th

e hi

ghes

t co

gniti

ve s

core

s in

tho

se w

ith n

eith

er r

isk

fact

or a

t b

asel

ine,

the

low

est

scor

es in

tho

se w

ith b

oth

risk

fact

ors

and

an

inte

rmed

iate

leve

l fo

r th

ose

with

one

ris

k fa

ctor

.R

esul

ts s

how

ed t

hat

a sc

ore

of 1

or

2 w

as w

orse

tha

n a

scor

e of

0 fo

r vi

sual

rep

rod

uctio

n (P

<0.

002)

and

tha

t a

scor

e of

2 w

as w

orse

th

an a

sco

re o

f 0 o

r 1

for

logi

cal m

emor

y d

elay

ed r

ecal

l (P

<0.

03).

Not

sta

ted

Unw

eigh

ted

ris

k fa

ctor

sc

ore.

Con

tinue

d

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 13: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

13Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

Stu

dy

Res

ult

Co

vari

ates

ad

just

ed f

or

Ris

k fa

cto

r ha

ndlin

g

Hon

olul

u A

sia

Age

ing

Stu

dy88

Ris

k fa

ctor

sco

res

>1

SD

ab

ove

the

mea

n w

ere

cons

ider

ed t

o b

e el

evat

ed; 2

4% h

ad n

o el

evat

ed r

isk

fact

ors,

29%

had

1 a

nd 3

0% h

ad

2 or

mor

e.P

er o

ne u

nit

incr

ease

in s

umm

ed z

sco

re a

dju

sted

for

age

and

ed

ucat

ion,

for

dem

entia

rel

ativ

e ris

k (R

R) 1

.06

(95%

CI 1

.02

to 1

.10)

, AD

R

R 1

.00

(95%

0.9

4 to

1.0

6), v

ascu

lar

dem

entia

(VaD

) RR

1.1

1 (1

.04

to 1

.18)

.C

omp

ared

with

tho

se w

ith n

o el

evat

ed r

isk

fact

ors,

for

dem

entia

1 ris

k fa

ctor

RR

0.9

(95%

CI 0

.62

to 1

.32)

.≥2

risk

fact

ors

RR

1.5

6 (9

5% C

I 1.1

2 to

2.1

8). R

esul

ts w

ere

stro

nger

for

VaD

.

Age

and

ed

ucat

ion

Unw

eigh

ted

ris

k fa

ctor

sc

ore.

Hoo

rn S

tud

y102

OR

per

poi

nt in

crea

se in

ris

k fa

ctor

sco

re w

hen

only

mod

ifiab

le r

isk

fact

ors

are

incl

uded

.In

form

atio

n p

roce

ssin

g sp

eed

OR

1.2

2 (9

5% C

I 0.9

9 to

1.5

1). A

tten

tion

and

exe

cutiv

e fu

nctio

n O

R 1

.26

(95%

CI 1

.04

to 1

.54)

. V

isuo

cons

truc

tion

OR

1.2

6 (9

5% C

I 0.9

4 to

1.6

9).

Ab

stra

ct r

easo

ning

OR

1.2

5 (9

5% C

I 0.9

1 to

1.7

1).

Lang

uage

OR

1.0

9 (9

5% C

I 0.7

9 to

1.5

1).

Mem

ory

OR

0.8

4 (9

5% C

I 0.6

8 to

1.0

3).

Z s

core

s w

ere

adju

sted

on

an in

div

idua

l bas

is fo

r ag

e,

sex,

IQ.

Wei

ghte

d r

isk

fact

or

scor

e, m

odifi

able

ris

k fa

ctor

sco

re w

as

unw

eigh

ted

.

Inte

rven

tion

pro

ject

on

cere

bro

vasc

ular

dis

ease

an

d d

emen

tia in

the

d

istr

ict

of E

ber

sber

g104

For

tota

l sco

re:

Sco

re 9

–12

HR

1 r

efer

ence

Sco

re 5

–8 H

R 0

.98

(95%

CI 0

.72

to 1

.33)

Sco

re 0

–4 H

R 1

.41

(95%

CI 0

.91

to 2

.20)

For

blo

od p

aram

eter

s al

one:

Sco

r e 4

–6 H

R 1

ref

eren

ceS

core

3 H

R 0

.79

(95%

CI 0

.60

to 1

.05)

Sco

re 0

–2 H

R 0

.95

(95%

CI 0

.72

to 1

.25)

For

heal

th b

ehav

iour

s al

one:

Sco

re 4

–6 H

R 1

ref

eren

ceS

core

3 H

R 0

.98

(95%

CI 0

.73

to 1

.31)

Sco

r e 0

–2 H

R 1

.41

(95%

CI 1

.28

to 1

.80)

Age

, sex

, ed

ucat

ion.

Unw

eigh

ted

ris

k fa

ctor

sc

ore.

Kai

ser

Per

man

ente

M

edic

al C

are

Pro

gram

93C

ard

iova

scul

ar c

omp

osite

sco

re fo

r ris

k of

dem

entia

:1

risk

fact

or H

R 1

.27

(95%

CI 1

.02

to 1

.58)

2 ris

k fa

ctor

s H

R 1

.59

(95%

CI 1

.28

to 1

.98)

3 ris

k fa

ctor

s H

R 2

.19

(95%

CI 1

.63

to 2

.93)

4 ris

k fa

ctor

s H

R 2

.61

(95%

CI 1

.22

to 5

.60)

Age

at

mid

life,

age

at

case

asc

erta

inm

ent,

rac

e,

educ

atio

n, s

ex.

Unw

eigh

ted

ris

k fa

ctor

sc

ore.

Kun

gsho

lmen

pro

ject

100

In o

ver

6406

par

ticip

ant

year

s of

follo

w-u

p, t

here

wer

e 42

8 ca

ses

of d

emen

tia in

clud

ing

328

of A

D. O

vera

ll, h

ighe

r ris

k sc

ores

wer

e as

soci

ated

with

gre

ater

ris

k of

inci

den

t d

emen

tia a

nd A

D. O

vera

ll va

scul

ar r

isk

pro

file

scor

eD

emen

tia0

Ref

eren

ce c

ateg

ory

1 ho

ur 1

.11

(95%

CI 0

.79

to 1

.58)

2 ho

urs

1.65

(95%

CI 1

.12

to 2

.42)

≥3 h

ours

2.4

8 (9

5% C

I 1.4

6 to

4.2

0), p

for

tren

d <

0.00

1A

D 0

ref

eren

ce c

ateg

ory

1 ho

ur 1

.09

(95%

CI 0

.75

to 1

.60)

2 ho

urs

1.77

(95%

CI 1

.16

to 2

.71)

≥3 h

ours

2.6

6 (9

5% C

I 1.3

9 to

5.0

8), p

for

tren

d <

0.00

1. S

imila

r p

atte

rns,

ath

eros

cler

otic

ris

k p

rofil

e, h

ypop

erfu

sion

ris

k p

rofil

e.

Age

, sex

, ed

ucat

ion,

bas

elin

e M

ini-

Men

tal S

tate

Exa

min

atio

n (M

MS

E),

BM

I, an

tihyp

erte

nsiv

e us

e, c

oron

ary

hear

t d

isea

se,

AP

OE

ε4

and

sur

viva

l sta

tus

at

follo

w-u

p.

Unw

eigh

ted

ris

k fa

ctor

sc

ore.

Maa

stric

ht A

gein

g S

tud

y103

Ris

k sc

ore

and

inci

den

t d

emen

tia H

R 1

.19

(95%

CI 1

.08

to 1

.32)

.R

isk

scor

e an

d in

cid

ent

cogn

itive

dec

line

HR

1.0

9 (9

5% C

I 1.0

04 t

o 1.

18).

No

asso

ciat

ion

for

linea

r m

ixed

mod

els.

Per

poi

nt in

crea

se in

ris

k sc

ore.

Age

, sex

and

ed

ucat

ion.

Wei

ghte

d r

isk

fact

or

scor

e.

Tab

le 3

C

ontin

ued

Con

tinue

d

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 14: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

14 Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

Stu

dy

Res

ult

Co

vari

ates

ad

just

ed f

or

Ris

k fa

cto

r ha

ndlin

g

Nor

ther

n M

anha

ttan

S

tud

y91A

naly

sis

excl

udin

g th

ose

with

cog

nitiv

e im

pai

rmen

t at

bas

elin

e. F

or c

hang

e in

Exe

cutiv

e fu

nctio

n2

vs 0

–1 id

eal h

ealth

fact

ors

bet

a 0.

076

(SE

0.1

16),

p=

0.51

3.3

vs 0

–1 id

eal h

ealth

fact

ors

bet

a 0.

325

(SE

0.1

18),

p=

0.00

6.4–

7 vs

0–1

idea

l hea

lth fa

ctor

s b

eta

0.09

1 (S

E 0

.133

), p

=0.

497.

Sem

antic

mem

ory

2 vs

0–1

idea

l hea

lth fa

ctor

s b

eta

0.22

0 (S

E 0

.111

), p

=0.

047.

3 vs

0–1

idea

l hea

lth fa

ctor

s b

eta

0.22

4 (S

E 0

.112

), p

=0.

047.

4–7

vs 0

–1 id

eal h

ealth

fact

ors

bet

a 0.

222

(SE

0.1

28),

p=

0.08

2.E

pis

odic

mem

ory

2 vs

0–1

idea

l hea

lth fa

ctor

s b

eta

0.26

8 (S

E 0

.115

), p

=0.

020.

3 vs

0–1

idea

l hea

lth fa

ctor

s b

eta

0.32

1 (S

E 0

.117

), p

=0.

006.

4–7

vs 0

–1 id

eal h

ealth

fact

ors

bet

a 0.

314

(SE

0.1

32),

p=

0.01

8.P

roce

ssin

g sp

eed

2 vs

0–1

idea

l hea

lth fa

ctor

s b

eta

0.34

3 (S

E 0

.115

), p

=0.

003.

3 vs

0–1

idea

l hea

lth fa

ctor

s b

eta

0.39

2 (S

E 0

.117

), p

=0.

001.

4–7

vs 0

–1 id

eal h

ealth

fact

ors

bet

a 0.

489

(SE

0.1

33),

p<

0.00

1.

Sex

, rac

e, m

edic

al in

sura

nce,

tim

e fr

om b

asel

ine

to

neur

opsy

chol

ogic

al d

ata

colle

ctio

n w

ave

1.

Unw

eigh

ted

ris

k fa

ctor

sc

ore.

Per

sona

lity

and

Tot

al

Hea

lth, P

ath

thro

ugh

life

stud

y108

Ove

rall

high

er P

ATH

risk

scor

e w

as a

ssoc

iate

d w

ith p

oore

r co

gniti

ve fu

nctio

n on

all

cogn

itive

tes

ts e

xcep

t re

actio

n tim

e. F

or

rela

tions

hip

s b

etw

een

PATH

risk

and

cha

nge

in c

ogni

tive

mea

sure

s ov

er t

ime:

the

mod

el in

clud

ing

gend

er, t

ime,

PAT

Hris

k*tim

e an

d

PATH

risk:

foun

d a

n as

soci

atio

n b

etw

een

PATH

risk*

time

and

cho

ice

reac

tion

time

(bet

a −

0.02

4 (S

E 0

.01)

) The

mod

el in

clud

ing

gend

er,

time,

ed

ucat

ion,

tim

e*PA

THris

k an

d e

duc

atio

n*PA

THris

k fo

und

no

asso

ciat

ion

bet

wee

n PA

THris

k*tim

e an

d c

ogni

tive

scor

e ch

ange

. No

rela

tions

hip

for

ind

ivid

ual r

isk

fact

ors.

No

rela

tions

hip

with

glo

bal

cog

nitiv

e sc

ore.

Pat

tern

s of

tes

t co

mp

letio

n.U

nwei

ghte

d r

isk

fact

or

scor

e.

San

Lui

s Va

lley

Hea

lth

ad A

ging

Stu

dy92

The

His

pan

ic p

opul

atio

n ha

d a

wor

se r

isk

fact

or p

rofil

e th

an t

he w

hite

pop

ulat

ion.

Gen

eral

cog

nitiv

e d

eclin

e (M

MS

E) a

ny 1

ris

k fa

ctor

OR

1.0

9 (9

5% C

I 0.7

0 to

1.7

1), a

ny 2

ris

k fa

ctor

s O

R 1

.10

(95%

CI 0

.69

to 1

.73)

, all

3 ris

k fa

ctor

s O

R 1

.15

(95%

CI 0

.63

to 2

.12)

.E

xecu

tive

func

tion

dec

line

(Beh

avio

ural

Dys

cont

rol S

cale

) any

1 r

isk

fact

or O

R 1

.07

(95%

CI 0

.59

to 1

.92)

, any

2 r

isk

fact

ors

OR

1.1

6 (9

5% C

I 0.6

4 to

2.1

1), a

ll 3

risk

fact

ors

OR

1.4

5 (9

5% C

I 0.6

9 to

3.0

7).

Dec

ade

of a

ge a

nd e

duc

atio

n.

Com

par

ator

not

cle

ar:

assu

med

to

be

no r

isk

fact

ors.

Unw

eigh

ted

ris

k fa

ctor

sc

ore.

Sup

ple

men

tatio

n en

vi

tam

ines

et

min

erau

x an

tioxy

dan

ts s

tud

y105

In t

he fi

nal m

odel

, ad

just

ing

for

othe

r lif

esty

le r

isk

fact

ors

plu

s th

ose

in n

ext

colu

mn,

the

onl

y st

atis

tical

ly s

igni

fican

t re

latio

nshi

p

rem

aini

ng w

as fo

r al

coho

l com

par

ing

abst

aine

rs t

o us

ers

−1.

26 (9

5% C

I –2.

11 t

o −

0.40

) suc

h th

at a

bst

aine

rs h

ad p

oore

r ve

rbal

mem

ory

outc

omes

.Fo

r sc

ore

of u

nhea

lthy

beh

avio

urs:

Com

par

ed w

ith 0

–1 u

nhea

lthy

beh

avio

urs:

for

glob

al c

omp

osite

cog

nitiv

e p

erfo

rman

ce a

t fo

llow

-up

.2

unhe

alth

y b

ehav

iour

s m

ean

diff

eren

ce in

cog

nitiv

e p

erfo

rman

ce −

1.57

(95%

CI −

2.98

to

−0.

16).

3 un

heal

thy

beh

avio

urs

mea

n d

iffer

ence

in c

ogni

tive

per

form

ance

−1.

69 (9

5% C

I −3.

06 t

o −

0.33

).4

unhe

alth

y b

ehav

iour

s m

ean

diff

eren

ce in

cog

nitiv

e p

erfo

rman

ce −

1.75

(95%

CI −

3.20

to

−0.

30).

5–6

unhe

alth

y b

ehav

iour

s m

ean

diff

eren

ce in

cog

nitiv

e p

erfo

rman

ce −

2.10

(95%

CI −

3.82

to

−0.

37).

Sim

ilar

pat

tern

s fo

r sc

ore

used

as

a co

ntin

uous

var

iab

le a

nd fo

r th

e sa

me

anal

yses

with

exe

cutiv

e fu

nctio

n an

d v

erb

al m

emor

y ou

tcom

es. W

hen

look

ing

at la

tent

life

styl

e fa

ctor

s, lo

w fr

uit

and

veg

etab

le c

onsu

mp

tion

and

low

phy

sica

l act

ivity

leve

l ap

pea

red

to

be

the

mai

n co

ntrib

utor

s to

the

unh

ealth

y b

ehav

iour

s re

late

d t

o ve

rbal

mem

ory.

The

unh

ealth

y lif

esty

le la

tent

fact

or w

as n

ot a

ssoc

iate

d

with

exe

cutiv

e fu

nctio

n.

Age

, sex

, ed

ucat

ion,

tim

e-la

g b

asel

ine

to c

ogni

tive

eval

uatio

n, o

ccup

atio

nal

stat

us, t

rial i

nter

vent

ion

grou

p, e

nerg

y in

take

, num

ber

of

24

hour

s re

cord

s, B

MI,

dep

ress

ive

sym

pto

ms,

b

asel

ine

self-

rep

orte

d

mem

ory

trou

ble

s, h

isto

ry o

f d

iab

etes

, hyp

erte

nsio

n an

d

card

iova

scul

ar d

isea

ses.

Clu

ster

ing:

late

nt fa

ctor

s/un

wei

ghte

d s

corin

g.

Suw

on L

ongi

tud

inal

A

gein

g S

tud

y109

Gre

ater

num

ber

of p

ositi

ve fa

ctor

s (n

on-s

mok

ing,

veg

etab

le c

onsu

mp

tion,

phy

sica

l act

ivity

and

soc

ial a

ctiv

ity) a

ssoc

iate

d w

ith g

reat

er

chan

ge o

n M

MS

E.

Imp

lied

tha

t ch

ange

is a

ssoc

iate

d w

ith p

ositi

ve c

ogni

tive

outc

ome.

1 p

rote

ctiv

e fa

ctor

bet

a 0.

441

(SE

0.3

48).

2 p

rote

ctiv

e fa

ctor

s b

eta

1.35

3 (S

E 0

.348

).3

pro

tect

ive

fact

ors

bet

a 1.

731

(SE

0.3

62).

Whe

n al

l fac

tors

ent

ered

into

the

sam

e m

odel

onl

y ve

geta

ble

con

sum

ptio

n an

d s

ocia

l act

ivity

rem

aine

d s

tatis

tical

ly s

igni

fican

t. N

on-

smok

ing

bet

a 0.

393

(SE

0.2

53).

Phy

sica

l act

ivity

bet

a 0.

310

(SE

0.1

95).

Vege

tab

le c

onsu

mp

tion

bet

a 0.

698

(SE

0.1

76).

Soc

ial a

ctiv

ity

bet

a 0.

626

(SE

0.1

87).

No

obvi

ous

pat

tern

in p

artic

ular

com

bin

atio

ns o

f pro

tect

ive

fact

ors.

The

se a

naly

ses

incl

ude

the

who

le d

ata

set

with

out

excl

usio

n of

tho

se w

ith p

reva

lent

cog

nitiv

e im

pai

rmen

t. T

he a

utho

rs r

epor

t th

at t

hey

carr

ied

out

sen

sitiv

ity a

naly

ses

excl

udin

g th

ose

with

MM

SE

sco

res<

19 a

nd t

hat

the

mag

nitu

de

of t

he a

ssoc

iatio

n d

imin

ishe

d, a

lthou

gh t

he d

irect

ion

of t

he a

ssoc

iatio

n d

id n

ot

chan

ge.

Age

, sex

, mar

ital s

tatu

s,

educ

atio

n, li

fetim

e oc

cup

atio

n,

dia

bet

es, h

eart

dis

ease

, hy

per

tens

ion

and

str

oke.

Unw

eigh

ted

ris

k fa

ctor

sc

ore.

Tab

le 3

C

ontin

ued

Con

tinue

d

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 15: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

15Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

Stu

dy

Res

ult

Co

vari

ates

ad

just

ed f

or

Ris

k fa

cto

r ha

ndlin

g

Up

psa

la L

ongi

tud

inal

S

tud

y of

Ad

ult

Men

98R

isk

fact

ors

at a

ge 5

0, r

efer

ence

non

eA

D:

1: H

R 0

.9 (9

5% C

I 0.6

to

1.5)

;2:

HR

1.2

(95%

CI 0

.8 t

o 2.

0);

≥3: H

R 0

.5 (9

5% C

I 0.2

to

1.2)

.Va

scul

ar d

emen

tia:

1: H

R 2

.1 (9

5% C

I 0.9

to

4.6)

;2:

HR

2.8

(95%

CI 1

.3 t

o 6.

2);

≥3: H

R 5

.1 (9

5% C

I 2.2

to

11.9

).A

D, m

ixed

or

unsp

ecifi

ed d

emen

tia:

1: H

R 1

.3 (9

5% C

I 0.9

to

1.9)

;2:

HR

1.5

(95%

CI 1

.0 t

o 2.

2);

≥3: H

R 1

.4 (9

5% C

I 0.9

to

1.4)

All

dem

entia

:1:

HR

1.4

(95%

CI 1

.0 t

o 1.

9);

2: H

R 1

.7 (9

5% C

I 1.2

to

2.3)

;≥3

: HR

2.1

(95%

CI 1

.5 t

o 3.

2).

Ris

k fa

ctor

s at

age

70

year

s—re

fere

nce

none

AD

:1:

HR

1.0

(95%

CI 0

.8 t

o 2.

3);

2: H

R 2

:1.0

(95%

CI 0

.6 t

o 1.

9);

≥3: H

R 0

.4 (9

5% C

I 0.1

to

1.3)

.Va

scul

ar d

emen

tia:

1: H

R 4

.1 (9

5% C

I 1.0

to

17.7

);2:

HR

6.8

(95%

CI 1

.6 t

o 29

.2);

≥3: H

R 7

.7 (9

5% C

I 1.6

to

37.1

).A

D, m

ixed

or

unsp

ecifi

ed d

emen

tia:

1: H

R 1

.6 (9

5% C

I 1.1

to

2.5)

;2:

HR

1.4

(0.9

to

2.2)

;≥3

: HR

1.1

(0.5

to

2.1)

All

dem

entia

:1:

HR

1.8

(95%

CI 1

.2 t

o 2.

6);

2: H

R 1

.7 (9

5% C

I 1.1

to

2.6)

;≥3

: HR

1.7

(95%

CI 1

.0 t

o 2.

9).

Age

and

ed

ucat

ion.

Unw

eigh

ted

ris

k fa

ctor

sc

ore.

Was

hing

ton

Hei

ghts

co

hort

89Fo

r p

rob

able

and

pos

sib

le A

D c

omb

ined

, dia

bet

es, h

yper

tens

ion,

hea

rt d

isea

se a

nd s

mok

ing

wer

e re

tain

ed in

mul

tivar

iab

le a

naly

ses;

26

.0%

had

no

risk

fact

ors,

37.

8% h

ad 1

ris

k fa

ctor

, 25.

3% h

ad 2

ris

k fa

ctor

s, 9

.4%

had

3 r

isk

fact

ors

and

0.9

% h

ad a

ll ris

k fa

ctor

s.W

hen

all f

our

risk

fact

ors

wer

e in

clud

ed in

the

sam

e m

odel

onl

y d

iab

etes

(HR

2.0

(95%

CI 1

.4 t

o 2.

9) a

nd c

urre

nt s

mok

ing

(HR

1.9

(95%

C

I 1.4

to

2.9)

ret

aine

d s

tatis

tical

sig

nific

ance

. The

cor

resp

ond

ing

resu

lts fo

r he

art

dis

ease

and

hyp

erte

nsio

n w

ere

HR

1.1

(95%

CI 0

.8 t

o 1.

5) a

nd H

R 1

.1 (9

5% C

I 0.9

to

1.5)

.W

hen

num

ber

of r

isk

fact

ors

was

exa

min

ed:

Com

par

ed w

ith n

o ris

k fa

ctor

s fo

r p

rob

able

or

pos

sib

le A

D:

1 ris

k fa

ctor

HR

1.6

(95%

CI 1

.1 t

o 2.

4);

2 ris

k fa

ctor

s H

R 2

.6 (9

5% C

I 1.7

to

3.8)

;3

or 4

ris

k fa

ctor

s H

R 3

.8 (9

5% C

I 2.4

to

5.9)

.

Age

and

sex

, a s

ubsa

mp

le

add

ition

ally

ad

just

ed fo

r ed

ucat

ion

and

AP

OE

ε4

show

ed s

imila

r re

sults

.

Unw

eigh

ted

ris

k fa

ctor

sc

ore.

Was

hing

ton

Hei

ghts

co

hort

97C

omb

ined

die

t an

d p

hysi

cal a

ctiv

ity. F

or t

he s

amp

le e

xclu

din

g th

ose

with

a b

asel

ine

clin

ical

dem

entia

rat

ing

scal

e sc

ore

of 0

.5 a

nd w

ith

<2

year

s fo

llow

-up

.Lo

w a

ctiv

ity, l

ow d

iet

AD

HR

1.0

0 re

fere

nce;

Low

act

ivity

, hig

h d

iet

HR

0.7

0 (9

5% C

I 0.5

0 to

1.2

8);

Hig

h ac

tivity

, low

die

t sc

ore

HR

0.6

1 (9

5% C

I 0.3

8 to

0.9

7);

Hig

h ac

tivity

, hig

h d

iet

scor

e H

R 0

.51

(95%

CI 0

.31

to 0

.83)

;P

atte

rns

of r

esul

ts w

ere

sim

ilar

for

the

who

le s

amp

le.

Coh

ort,

age

, sex

, eth

nici

ty,

educ

atio

n, A

PO

E ε

4 st

atus

, ca

loric

inta

ke, B

MI,

smok

ing,

d

epre

ssio

n, le

isur

e ac

tiviti

es,

com

orb

idity

ind

ex, t

ime

bet

wee

n fir

st d

ieta

ry a

nd fi

rst

phy

sica

l act

ivity

ass

essm

ent.

Wei

ghte

d r

isk

fact

or

scor

e.

Was

hing

ton

Hei

ghts

co

hort

94N

o re

al im

pac

t of

vas

cula

r b

urd

en o

n co

gniti

ve c

hang

e, r

isk

fact

ors

wer

e as

soci

ated

with

a s

mal

l att

enua

ted

dec

line

in m

emor

y on

b

lack

but

not

whi

te o

r H

isp

anic

par

ticip

ants

.Fo

r an

nual

cha

nge

in g

ener

al c

ogni

tive

per

form

ance

; whi

te −

0.03

(95%

CI −

0.13

to

0.07

), b

lack

0.1

0 (9

5% C

I 0.0

2 to

0.1

8), H

isp

anic

0.

06 (9

5% C

I −0.

02 t

o 0.

14);

For

annu

al c

hang

e in

exe

cutiv

e fu

nctio

n; w

hite

−0.

03 (9

5% C

I −0.

13 t

o 0.

07),

bla

ck 0

.02

(95%

CI −

0.06

to

0.10

), H

isp

anic

0.0

(95%

CI

−0.

06 t

o 0.

10);

For

annu

al c

hang

e in

mem

ory;

whi

te 0

.00

(95%

CI −

0.10

to

0.10

), b

lack

0.1

1 (9

5% C

I 0.0

5 to

0.1

7), H

isp

anic

0.0

6 (9

5% C

I 0.0

0 to

0.

12).

Age

, sex

, ed

ucat

ion,

re

crui

tmen

t co

hort

and

AP

OE

ε4

sta

tus.

Unw

eigh

ted

ris

k fa

ctor

sc

ore.

Tab

le 3

C

ontin

ued

Con

tinue

d

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 16: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

16 Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

Stu

dy

Res

ult

Co

vari

ates

ad

just

ed f

or

Ris

k fa

cto

r ha

ndlin

g

Whi

teha

ll II

stud

y106

Slo

pes

from

gro

wth

cur

ve m

odel

s es

timat

ing

the

com

bin

ed e

ffect

of a

lcoh

ol a

nd s

mok

ing

at b

asel

ine

(199

7–19

99) o

n co

gniti

ve d

eclin

e (2

002–

2004

to

2007

–200

9). B

eing

a h

eavy

drin

ker

and

cur

rent

sm

oker

was

ass

ocia

ted

with

fast

er d

eclin

e.N

on-d

rinke

r an

d:

Nev

er s

mok

er −

0.40

(95%

CI −

0.46

to

−0.

34);

Ex-

smok

er −

0.38

(95%

CI −

0.46

to

−0.

30);

Cur

rent

sm

oker

−0.

50 (9

5% C

I −0.

65 t

o −

0.35

).M

oder

ate

drin

ker

(with

in U

K r

ecom

men

ded

lim

its) a

nd:

Nev

er s

mok

er −

0.42

(95%

CI −

0.45

to

−0.

39);

Ex-

smok

er −

0.42

(95%

CI −

0.45

to

−0.

38);

Cur

rent

sm

oker

−0.

37 (9

5% C

I −0.

44 t

o −

0.29

).H

eavy

drin

ker

(>U

K re

com

men

ded

lim

its) a

nd:

Nev

er s

mok

er −

0.42

(95%

CI −

0.47

to

−0.

37);

Ex-

smok

er −

0.45

(95%

CI −

0.49

to

−0.

41);

Cur

rent

sm

oker

−0.

57 (9

5% C

I −0.

67 t

o −

0.48

).S

ensi

tivity

ana

lysi

s to

exc

lud

e th

ose

with

MM

SE

<24

at

follo

w-u

p s

how

ed s

imila

r re

sults

.

Age

, gen

der

, pre

vale

nt c

hron

ic

dis

ease

and

ed

ucat

ion

Use

d c

ateg

orie

s to

ex

amin

e ad

diti

ve im

pac

t.

Whi

teha

ll II

stud

y107

At

bas

elin

e: 8

.4%

had

no

unhe

alth

y b

ehav

iour

s. O

ther

dat

a no

t gi

ven.

Exa

min

ing

the

rela

tions

hip

bet

wee

n un

heal

thy

beh

avio

urs

at

pha

se I

and

poo

r ex

ecut

ive

func

tion

at p

hase

VII:

Com

par

ed w

ith n

o un

heal

thy

beh

avio

urs:

Thos

e w

ith:

1 un

heal

thy

beh

avio

ur O

R 1

.34

(95%

CI 0

.96

to 1

.87)

;2

unhe

alth

y b

ehav

iour

s O

R 1

.38

(95%

CI 0

.99

to 1

.93)

;3–

4 un

heal

thy

beh

avio

urs

OR

1.8

4 (9

5% C

I 1.2

7 to

2.6

5).

Exa

min

ing

the

rela

tions

hip

bet

wee

n un

heal

thy

beh

avio

urs

at p

hase

I an

d p

oor

exec

utiv

e fu

nctio

n at

pha

se V

: com

par

ed w

ith n

o un

heal

thy

beh

avio

urs:

Thos

e w

ith:

1 un

heal

thy

beh

avio

ur O

R 1

.38

(95%

CI 1

.09

to 1

.74)

;2

unhe

alth

y b

ehav

iour

s O

R 1

.83

(95%

CI 1

.43

to 2

.33)

;3–

4 un

heal

thy

beh

avio

urs

OR

2.3

8 (9

5% C

I 1.7

6 to

3.2

2).

Sim

ilar

pat

tern

for

unhe

alth

y b

ehav

iour

at

pha

se I

and

mem

ory.

No

clea

r p

atte

rns

for

diff

eren

t co

mb

inat

ions

of h

ealth

beh

avio

urs.

Cum

ulat

ive

scor

e of

sum

med

hea

lth b

ehav

iour

s ov

er t

ime.

Com

par

ed w

ith t

hose

sco

ring

0–2:

for

exec

utiv

e fu

nctio

n:3–

5 O

R 1

.58

(95%

CI 1

.27

to 1

.98)

;6–

8 O

R 2

.52

(95%

CI 1

.96

to 3

.24)

;9–

12 O

R 2

.87

(95%

CI 1

.90

to 4

.32)

.S

imila

r p

atte

rn fo

r m

emor

y.

Age

, sex

and

soc

ioec

onom

ic

pos

ition

at

the

corr

esp

ond

ing

stag

e of

ass

essm

ent.

Unw

eigh

ted

ris

k fa

ctor

sc

ore.

Tab

le 3

C

ontin

ued

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 17: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

17Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

supplementary text 2). For AD,89 98 100 fixed effect pooled risk ratios for one risk factor were 1.2 (95% CI 0.9 to 1.5), for two risk factors 1.8 (95% CI 1.4 to 2.3) and for three or more risk factors 1.2 (95% CI 0.2 to 6.1). The results for the random effects model were 1.2 (95% CI 0.9 to 1.6) for one risk factor, 1.8 (95% CI 1.2 to 2.8) for two risk factors and 1.5 (95% CI 0.9 to 2.5) for three or more risk factors. For AD, the heterogeneity was high and the number of constituent studies was low, restricting anal-ysis of publication bias (online supplementary text 2). Visual examination of the plotted results per incremental risk factor for the studies included in the meta-analysis showed no clear pattern by study baseline age, population sex distribution, length of follow-up or study covariates; however, the small numbers precluded meta-regression or other formal statistical testing.

study qualityOf the 22 articles, 14 were assessed as having an overall medium risk of bias88 92 93 95 96 98 99 101 102 104–107 109; 7 as having a low risk89 90 94 97 100 103 108 and 1 as having high risk.91 Risk of bias was assessed with regard to recruitment, exposure (eg, assessments of risk factor exposure), outcome (eg, assessment tools, use of blinded assessors) and follow-up (eg, attrition, length of follow-up) (online supplemen-tary table 2). Several studies analysed population-based cohorts,89 92–97 99–103 108 109 some specifying that their anal-yses were based on selective populations.90 91 95 96 98 101 102 105 Two studies were specifically designed to recruit selective populations; the Honolulu Asia Ageing Study which only included Japanese American men living in Honolulu88 and the Whitehall study which recruited exclusively from a civil servant population.106 107 Two further studies

Figure 2 Forest plots showing dose response for exposure to increasing numbers of risk factors and risk of incident dementia for individual studies Follow-up 27 years for the Honolulu Asia Ageing Study (HAAS) cohort, 20 years for the Uppsala cohort, ~5 years for the Kungsholmen cohort, 26.7 for the Kaiser Permanente cohort and 21 years for the Cardiovascular Risk factors Ageing and Dementia (CAIDE) cohort. RF, risk factor; RR, relative risk.

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 18: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

18 Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

recruited from previously existing healthcare provider or insurance databases.93 104 All studies used recognised and standard measures to characterise baseline risk factors, although variation in the evidence base, current guide-lines and recommendations at the time of study data collection and analysis inevitably resulted in diverse risk factor definitions.

Regarding outcome measurement and length of follow-up, two studies reported follow-up likely to be <5 years, putting them at risk of reverse causality92 109; however, five studies reported long (ie, >20 years) follow-up88 90 93 96 101 and three of these reported incident dementia outcomes.88 93 101 Two studies used dementia outcomes taken from medical databases,93 104 which may have underestimated the number of cases, but all other studies used standard diagnostic criteria or standard neuropsychological tests. The majority of studies reported on incident dementia or on change in cognitive function assessed using neuropsycholog-ical tests; however, five studies reported cognitive func-tion only at follow-up, potentially including prevalent, rather than incident, cases of poor function.90 96 102 105 107 The majority of studies adjusted for age, sex and educa-tion, although some carried out further adjustment for wider covariates. Finally, details of how researchers had accounted for missing data and attrition were not consis-tently reported with information provided in around half the articles.90 92 94 96 97 99 100 105–108

DIsCussIOnThis systematic review of the evidence base relating to intraindividual co-occurring modifiable risk factors for dementia and cognitive decline found a clear rela-tionship between the presence of/exposure to greater numbers of baseline risk factors and an increased risk of later cognitive decline or incident dementia. The converse was also seen in identifying a relation-ship between greater numbers of protective factors or healthy behaviours and a reduced risk of cognitive decline or dementia.

Studies reporting risk ratios for all-cause dementia per incremental risk factor consistently demonstrated a clear dose-response relationship. When combined in a meta-analysis, a 20% increase in dementia risk with the presence of one risk factor (combined risk ratio 1.2 (95% CI 1.0 to 1.4)) was observed rising to 65% for two risk factors (1.7 (95% CI 1.4 to 1.9)). Presence of three risk factors doubled the risk of dementia with a combined risk ratio of 2.2 (95% CI 1.8 to 2.7). Fewer studies and incident cases were identified for a similar meta-analysis of AD with the dose response only being evident for the presence of one and two risk factors.

Although data relating to summed risk or protec-tive factors showed clear relationships with cognitive outcomes, limited data were available on clustering of specific risk factors and subsequent cognitive outcomes. Only three studies used statistical clustering techniques

and the methods are too diverse and the results too varied to allow conclusions to be drawn.

To our knowledge, this is the first review to examine the impact of intraindividual co-occurring modifiable risk factors and risk of dementia and cognitive decline. As such, comparison to prior similar work in this area is difficult, however, scoring systems involving the sum, or weighted sum of individual risk factors, including both modifiable and non-modifiable risk factors, have been widely used in other areas such as cancer,111 all-cause mortality112 and, especially, cardiovascular disease.113 A recent systematic review reported on 363 such cardio-vascular disease risk scores or models114 and several such cardiovascular and other scores have also been used to predict dementia outcomes.46 Our findings are congruent with such scoring systems and are biologically plausible with higher numbers of vascular risk factors in midlife associated with elevated amyloid deposition in addition to vascular damage.115 What our findings add is the first quantifiable estimation of the impact of risk factor accrual. What we were unable to add is evidence related to particular risk factor clusters. In fact, data on the impact of modifiable risk factor clusters are rare, although recent work on all-cause mortality found that combinations of specific risk factors, for example, phys-ical inactivity, prolonged sitting and short or long sleep duration are associated with higher levels of mortality risk.112

limitationsOur review is inevitably limited by its exclusive depen-dence on published results. This meant that we were unable to: i) statistically evaluate trends within individual studies, ii) evaluate the impact of additional covariates, iii) evaluate the impact of particular population char-acteristics or iv) the potential for particular risk factors having a greater or lesser impact. We were also unable to explore the relationship between specific risk factor clus-ters or between greater risk factor burden and cognition beyond that assessed by the included studies and there was considerable variability in the modifiable risk factors addressed in each study (online supplementary table 1), thus limiting the opportunity for unpicking individual factor impact. A further limitation relates to restricting inclusion to known and widely accepted modifiable risk factors. While this makes findings more amenable to public health dissemination, it may omit important unknown or emerging modifiable risk factors, such as air pollution.116 117 Furthermore, despite not being amenable to intervention and therefore not the focus of this review non-modifiable risk factors also undoubtedly play a role. The use of a binary classification for risk or protective factors, while clinically practical, may also have resulted in a loss of subtlety, particularly since definitions of risk differed across studies. Risk factors are also associated with participant attrition and few studies took this into account in modelling. Furthermore, few papers considered poten-tial treatment effects. Finally, although we concentrated

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 19: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

19Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

on adulthood, emerging evidence is suggesting a poten-tial role for accrual of exposure to vascular risk factors in childhood and poorer cognition in midlife.118

Inevitably results drawn from longitudinal cohort studies are subject to bias, and, as is often the case in systematic reviews, the length of follow-up, assessment of outcomes and use of covariates varied. The strength of the evidence also needs to take into account the two studies contributing more than one analysis. Further-more, generalisability may also be limited since the study populations were drawn exclusively from high-income countries and, as such, may reflect a more homogeneous, and potentially more medicated or treated, population than those in low-income and middle-income countries where risk factor prevalence, recognition and treatment rates may differ.

A further consideration in the existing studies is the way in which age is considered beyond its role as a covariate. Age is the most important risk factor for dementia well into the tenth decade119 and although not a modifiable risk factor, it is a source of important and thus far poorly understood heterogeneity in risk for many diseases of older age, including dementia.120 The role of age, or time, in evaluating duration, as well as presence, of risk factors may be key and so far few studies have exam-ined this.121–126 Ageing is associated with widespread processes of deficit accumulation: beginning at molec-ular and subcellular levels,127 and scaling up128 to become detectable as biomarkers129; then by routine laboratory methods130 and then clinically.130 In general, the studies of deficit accumulation, in both general samples and in special groups such as people with HIV-AIDS131 or intel-lectual disabilities,132 show that any risk factors which are age-related and adverse (eg, associated with mortality) will increase the risk of cognitive decline. This some-times raises the objection that combining deficits in this manner makes it hard to know which ones are important. The counterargument is that this is not how age-related disease works. Often, many of the factors that in the aggre-gate are strongly associated with dementia (and which notably reduce the explanatory value of age) are not themselves significantly associated with cognitive decline when considered one at a time.124–126 The better remedy is to consider which other factors might mitigate (eg, health protective behaviours) or exacerbate (eg, social vulnerability) the adverse effects of such deficits on cogni-tion.125 As this approach is comparatively new—at least in its application to cognitive decline and dementia—there is as yet little to review. Given, however, the recent report from two prospective, community-based autopsy studies, showing that in one-quarter of patients with a history of delirium, accelerated cognitive decline was not related to classical neuropathology suggests that there is much to learn about how late-life dementia is related to overall health.133 Such observations encourage widening the scope of investigative approaches.

Notwithstanding these limitations, this is the most comprehensive and, to our knowledge, the first synthesis

of evidence on the impact of co-occurring risk factors for dementia. It presents an evidence base that is largely consistent and may imply a potentially very simple rela-tionship such that the higher the number of risk factors to which a person is exposed the greater their risk. The potential for a causal relationship is supported by the consistent finding across studies, the use of popula-tion-based samples although with some inevitable risk of bias, the longitudinal nature of the data, the suggestion of a dose-response relationship and the strength of the association between the summed risk factors. Further research is required to determine whether particular combinations of risk factors have greater impacts on cognitive function than others, which clinical thresh-olds should be used to classify risk or whether relation-ships differ in different population groups, for example, at extreme age. More understanding is also needed for the relationship between modifiable and non-modifiable factors and risk factor combinations, not least to stratify population subgroups and identify those at highest risk. Currently, the best course of action for both individuals and health organisations would be to seek to keep modi-fiable risk factor exposure to a minimum and to prevent exposure to further risk factors. The current findings support the use of risk indices for screening those at high risk of dementia and indicated for intervention.

COnClusIOnsThe evidence relating to the impact of co-occurring, within individual, risk factors and the risk of cognitive decline or dementia is highly consistent. It demonstrates that greater numbers of risk factors are associated with worse cognitive outcomes and greater numbers of protec-tive factors with better cognitive outcomes. We provide quantitative evidence of a dose response such that one risk factor is associated with an 20% increase in risk of incident dementia, two risk factors with an 65% increased risk and three or more with a doubling of risk. Our results support the need for clinicians, public health organ-isations and individuals to keep risk factor exposure to a minimum and even where risk factors are present to prevent further accrual.

Acknowledgements The authors gratefully acknowledge the contribution and commitment of the participants and study teams from each of the constituent studies used in the review.

Contributors RP conceived and designed the study, carried out the data extraction, analysis and drafted the manuscript. AB helped design the study and the search strategy and commented on the manuscript. KR helped design the study, and commented on the manuscript. JP helped design the study, extracted the data and commented on the manuscript. CDE advised on the statistical methods and commented on the manuscript. KJA helped design the study and commented on the manuscript. All authors had full access to study data.

Funding No funding was received specifically for this work. RP is funded by the Australian Dementia Collaborative Research Centre. AB’s input into the literature search and review design was undertaken under his University of Sheffield employment contract. KR is funded through the Dalhousie Medical Research Foundation as the Kathryn Allen Weldon Professor of Alzheimer’s Research and receives research funding from the Canadian Institutes of Health Research, the

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 20: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

20 Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

Canadian Frailty Network and the Fountain Family Research Fund of the Queen Elizabeth II Health Sciences Centre. JP received no support from any organisation for the submitted work. KJA is funded by NHMRC Fellowship APP1102694.

Competing interests RP, AB, JP, CDE, KJA report no disclosures. KR founded DGI Clinical, which has contracts with pharma for individualised outcome measurement and for data analytics, including in dementia studies with Otsuka and Roche. In 2017, he participated in an Advisory Board meeting on dementia for Lundbeck and in 2014 spoke at a satellite symposium at the Alzheimer Association International Conference, sponsored by Nutricia.

Patient consent Not required.

Provenance and peer review Not commissioned; externally peer reviewed.

Data sharing statement The data supporting the results are publicly available in the published literature. RP affirms that the manuscript is an accurate honest and transparent account of the study being reported. No important aspects of the study have been omitted, any discrepancies between the study as planned and registered are explained. Funding bodies had no role in the inception, design, completion or publication of this work.

Open access This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.

rEFErEnCEs 1. Alzheimer’s Disease International. World alzheimer report 2014:

dementia and risk reduction. 2014 http://www. alz. co. uk/ research/ world- report- 2014.

2. Lincoln P, Fenton K, Alessi C, et al. The Blackfriars Consensus on brain health and dementia. The Lancet 2014;383:1805–6.

3. Poortinga W. The prevalence and clustering of four major lifestyle risk factors in an English adult population. Prev Med 2007;44:124–8.

4. Griffin B, Sherman KA, Jones M, et al. The clustering of health behaviours in older australians and its association with physical and psychological status, and Sociodemographic Indicators. Annals of Behavioral Medicine 2014;48:205–14.

5. Morris LJ, D'Este C, Sargent-Cox K, et al. Concurrent lifestyle risk factors: Clusters and determinants in an Australian sample. Prev Med 2016;84:1–5.

6. Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. The Lancet 2015;385:2255–63.

7. Siervo M, Harrison SL, Jagger C, et al. Metabolic syndrome and longitudinal changes in cognitive function: a systematic review and meta-analysis. Journal of Alzheimer’s Disease 2014;41:151–61.

8. Hao Z, Wu B, Wang D, et al. Association between metabolic syndrome and cognitive decline: a systematic review of prospective population-based studies. Acta Neuropsychiatr 2011;23:69–74.

9. Downer B, Veeranki SP, Wong R. A late life risk index for severe cognitive impairment in Mexico. Journal of Alzheimer’s Disease 2016;52:191–203.

10. Aarts S, van den Akker M, Tan FES, et al. Influence of multimorbidity on cognition in a normal aging population: a 12-year follow-up in the Maastricht Aging Study. Int J Geriatr Psychiatry 2011;26:1046–53.

11. Kåreholt I, Lennartsson C, Gatz M, et al. Baseline leisure time activity and cognition more than two decades later. Int J Geriatr Psychiatry 2011;26:65–74.

12. Agrigoroaei S, Lachman ME. Cognitive functioning in midlife and old age: combined effects of psychosocial and behavioral factors. J Gerontol B Psychol Sci Soc Sci 2011;66 Suppl 1:i130–i140.

13. Iyer GK, Alladi S, Bak TH, et al. Dementia in developing countries: Does education play the same role in India as in the West? Dement Neuropsychol 2014;8:132–40.

14. Viticchi G, Falsetti L, Buratti L, et al. Framingham risk score can predict cognitive decline progression in Alzheimer’s disease. Neurobiol Aging 2015;36:2940–5.

15. Ogunmoroti O, Allen NB, Cushman M, et al. Association between life’s simple 7 and noncardiovascular disease : the multi‐ethnic stu dy of Atherosclerosis. J Am Heart Assoc 2016;5:e003954.

16. Mielke MM, Rosenberg PB, Tschanz J, et al. Vascular factors predict rate of progression in Alzheimer disease. Neurology 2007;69:1850–8.

17. Wang R, Fratiglioni L, Laukka EJ, et al. Effects of vascular risk factors and APOE 4 on white matter integrity and cognitive decline. Neurology 2015;84:1128–35.

18. Shaw BA, Agahi N. Smoking and physical inactivity patterns during midlife as predictors of all-cause mortality and disability: a 39-year prospective study. Eur J Ageing 2014;11:195–204.

19. Song X, Mitnitski A, Rockwood K. Index variables for studying outcomes in vascular cognitive impairment. Neuroepidemiology 2005;25:196–204.

20. Tang Z, Zhou T, Luo Y, et al. Risk factors for cerebrovascular disease mortality among the elderly in beijing: a competing risk analysis. PLoS One 2014;9:e87884.

21. Soto-Gordoa M, Arrospide A, Moreno-Izco F, et al. Projecting burden of dementia in spain, 2010–2050: impact of modifying risk factors. Journal of Alzheimer’s Disease 2015;48:721–30.

22. Kim S, Cherbuin N, Anstey KJ. Assessing reliability of short and tick box forms of the ANU-ADRI: Convenient alternatives of a self-report Alzheimer’s disease risk assessment. Alzheimers Dement 2016;2:93–8.

23. Adams ML, Grandpre J. Dose-response gradients between a composite measure of six risk factors and cognitive decline and cardiovascular disease. Prev Med 2016;91:329–34.

24. Rosal MC, Ockene JK, Ma Y, et al. Behavioral risk factors among members of a health maintenance organization. Prev Med 2001;33:586–94.

25. Russ TC, Hamer M, Stamatakis E, et al. Does the Framingham cardiovascular disease risk score also have predictive utility for dementia death? An individual participant meta-analysis of 11,887 men and women. Atherosclerosis 2013;228:256–8.

26. Katon W, Pedersen HS, Ribe AR, et al. Effect of depression and diabetes mellitus on the risk for dementia. JAMA Psychiatry 2015;72:612–9.

27. Watts AS, Loskutova N, Burns JM, et al. Metabolic syndrome and cognitive decline in early alzheimer’s disease and healthy older ad ults. Journal of Alzheimer’s Disease 2013;35:253–65.

28. S. Laitala V, Kaprio J, Koskenvuo M, et al. Association and causal relationship of midlife obesity and related metabolic disorders with old age cognition. Current Alzheimer Research 2011;8:699–706.

29. Akbaraly TN, Kivimaki M, Shipley MJ, et al. Metabolic syndrome over 10 years and cognitive functioning in late midlife: the Whitehall II study. Diabetes Care 2010;33:84–9.

30. Singh-Manoux A, Hillsdon M, Brunner E, et al. Effects of physical activity on cognitive functioning in middle age: evidence from the whitehall ii prospective cohort study. Am J Public Health 2005;95:2252–8.

31. Fung AW, Leung GT, Lam LC. Modulating factors that preserve cognitive function in healthy ageing. East Asian Arch Psychiatry 2011;21:152–6.

32. Prus SG. Age, SES, and health: a population level analysis of health inequalities over the lifecourse. Sociol Health Illn 2007;29:275–96.

33. Strand BH, Rosness TA, Engedal K, et al. Interaction of apolipoprotein e genotypes, lifestyle factors and future risk of dementia-related mortality: the cohort of Norway (CONOR). Dement Geriatr Cogn Disord 2015;40:137–47.

34. Gureje O, Oladeji BD, Abiona T, et al. Profile and determinants of successful aging in the Ibadan Study of Ageing. J Am Geriatr Soc 2014;62:836–42.

35. Luck T, Luppa M, Briel S, et al. Mild cognitive impairment: incidence and risk factors: results of the leipzig longitudinal study of the aged. J Am Geriatr Soc 2010;58:1903–10.

36. Newson RS, Kemps EB. General lifestyle activities as a predictor of current cognition and cognitive change in older adults: a cross-sectional and longitudinal examination. J Gerontol B Psychol Sci Soc Sci 2005;60:P113–P120.

37. Luo Y, Waite LJ. The impact of childhood and adult ses on physical, mental, and cognitive well-being in later life. The Journals of Gerontology: Series B 2005;60:S93–S101.

38. Comijs HC, Kriegsman DM, Dik MG, et al. Somatic chronic diseases and 6-year change in cognitive functioning among older persons. Arch Gerontol Geriatr 2009;48:191–6.

39. Wilson RS, Scherr PA, Bienias JL, et al. Socioeconomic characteristics of the community in childhood and cognition in old age. Exp Aging Res 2005;31:393–407.

40. Morrow LA, Snitz BE, Rodriquez EG, et al. High medical co-morbidity and family history of dementia is associated with lower cognitive function in older patients. Fam Pract 2009;26:339–43.

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 21: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

21Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

41. Vemuri P, Lesnick TG, Przybelski SA, et al. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. Brain 2015;138:761–71.

42. Duff K, Mold J, Roberts M, et al. Medical burden and cognition in older patients in primary care: Selective deficits in attention. Archives of Clinical Neuropsychology 2007;22:569–75.

43. Burke SL, Maramaldi P, Cadet T, et al. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer’s disease development. Arch Gerontol Geriatr 2016;65:231–8.

44. Fors S, Agahi N, Shaw BA. Paying the price? The impact of smoking and obesity on health inequalities in later life. Scand J Public Health 2013;41:134–41.

45. Karp A, Paillard-Borg S, Wang H-X, et al. Mental, physical and social components in leisure activities equally contribute to decrease dementia risk. Dement Geriatr Cogn Disord 2006;21:65–73.

46. Harrison SL, de Craen AJM, Kerse N, et al. Predicting risk of cognitive decline in very old adults using three models: the framingham stroke risk profile; the cardiovascular risk factors, aging, and dementia model; and oxi-inflammatory biomarkers. J Am Geriatr Soc 2017;65:381–9.

47. Andrews SJ, Eramudugolla R, Velez JI, et al. Validating the role of the Australian National University Alzheimer’s Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years. Alzheimers Res Ther 2017;9:16.

48. Viswanathan A, Macklin EA, Betensky R, et al. The influence of vascular risk factors and stroke on cognition in late life: analysis of the nacc cohort. Alzheimer Dis Assoc Disord 2015;29:287–93.

49. Jefferson AL, Hohman TJ, Liu D, et al. Adverse vascular risk is related to cognitive decline in older adults. Journal of Alzheimer’s Disease 2015;44:1361–73.

50. Levin BE, Llabre MM, Dong C, et al. Modeling metabolic syndrome and its association with cognition: the northern manhattan study. Journal of the International Neuropsychological Society 2014;20:951–60.

51. Lorius N, Locascio JJ, Rentz DM, et al. Vascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum. Alzheimer Dis Assoc Disord 2015;29:18–25.

52. Durazzo TC, Mattsson N, Weiner MW. Interaction of cigarette smoking history with apoe genotype and age on amyloid level, glucose metabolism, and neurocognition in cognitively normal elders. Nicotine Tob Res 2016;18:204–11.

53. Yaffe K, Vittinghoff E, Pletcher MJ, et al. Early adult to midlife cardiovascular risk factors and cognitive function. Circulation 2014;129:1560–7.

54. Moroney JT, et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 1999;282:254–60.

55. Barnes DE, Covinsky KE, Whitmer RA, et al. Predicting risk of dementia in older adults: The late-life dementia risk index. Neurology 2009;73:173–9.

56. Gallucci M, Mazzuco S, Ongaro F, et al. Body mass index, lifestyles, physical performance and cognitive decline: The “Treviso Longeva (Trelong)” study. J Nutr Health Aging 2013;17:378–84.

57. Downer B, Kumar A, Veeranki SP, et al. Mexican-american dementia nomogram: development of a dementia risk index for mexican-american older adults. J Am Geriatr Soc 2016;64:e265–e269.

58. Pankratz VS, Roberts RO, Mielke MM, et al. Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging. Neurology 2015;84:1433–42.

59. Monastero R, Palmer K, Qiu C, et al. Heterogeneity in risk factors for cognitive impairment, no dementia: population-based longitudinal study from the kungsholmen project. The American Journal of Geriatric Psychiatry 2007;15:60–9.

60. Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011;77:461–8.

61. Mielke MM, Leoutsakos J-M, Tschanz JT, et al. Interaction between vascular factors and the apoe ε4 allele in predicting rate of progres sion in Alzheimer’s Disease. Journal of Alzheimer’s Disease 2011;26:127–34.

62. Kaffashian S, Dugravot A, Elbaz A, et al. Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores. Neurology 2013;80:1300–6.

63. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 2006;5:735–41.

64. Dregan A, Stewart R, Gulliford MC. Cardiovascular risk factors and cognitive decline in adults aged 50 and over: a population-based cohort study. Age Ageing 2013;42:338–45.

65. Virta JJ, Heikkilä K, Perola M, et al. Midlife cardiovascular risk factors and late cognitive impairment. Eur J Epidemiol 2013;28:405–16.

66. Warsch JRL, Rundek T, Paik MC, et al. Association between northern manhattan study global vascular risk score and successful aging. J Am Geriatr Soc 2013;61:519–24.

67. Mitnitski A, Skoog I, Song X, et al. A vascular risk factor index in relation to mortality and incident dementia. Eur J Neurol 2006;13:514–21.

68. Mehta HB, Mehta V, Tsai C-L, et al. Development and validation of the rxdx-dementia risk index to predict dementia in patients with type 2 diabetes and Hypertension. Journal of Alzheimer’s Disease 2016;49:423–32.

69. Unverzagt FW, McClure LA, Wadley VG, et al. Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology 2011;77:1729–36.

70. Hazzouri AZA, Haan MN, Neuhaus JM, et al. Cardiovascular risk score, cognitive decline, and dementia in older mexican americans: the role of sex and education. J Am Heart Assoc 2013;2:e004978.

71. Chou R-H, Chiu C-C, Huang C-C, et al. Prediction of vascular dementia and Alzheimer’s disease in patients with atrial fibrillation or atrial flutter using CHADS2 score. Journal of the Chinese Medical Association 2016;79:470–6.

72. Kesse-Guyot E, Lassale C, Assmann KE, et al. Are different vascular risk scores calculated at midlife uniformly associated with subsequent poor cognitive performance? Atherosclerosis 2015;243:286–92.

73. Exalto LG, Quesenberry CP, Barnes D, et al. Midlife risk score for the prediction of dementia four decades later. Alzheimer’s & Dementia 2014;10:562–70.

74. Szoeke C, Lehert P, Henderson VW, et al. Predictive factors for verbal memory performance over decades of aging: data from the women’s healthy ageing project. The American Journal of Geriatric Psychiatry 2016;24:857–67.

75. Takahashi PY, Caldwell CR, Targonski PV. Effect of vascular burden as measured by vascular indexes upon vascular dementia: a matched case-control study. Clin Interv Aging 2012;7:27–33.

76. McLennan SN, Mathias JL, Brennan LC, et al. Cognitive impairment predicts functional capacity in dementia-free patients with cardiovascular disease. J Cardiovasc Nurs 2010;25:390–7.

77. Lee Y, Back JH, Kim J, et al. Multiple socioeconomic risks and cognitive impairment in older adults. Dement Geriatr Cogn Disord 2010;29:523–9.

78. Lee Y, Back JH, Kim J, et al. Clustering of multiple healthy lifestyles among older Korean adults living in the community. Geriatr Gerontol Int 2012;12:515–23.

79. Nguyen H, Evans M, Zonderman A. Influence of medical conditions on executive and memory functions in low socioeconomic status African Americans. Archives of Clinical Neuropsychology 2007;22:689–98.

80. Falkowski J, Atchison T, DeButte-Smith M, et al. Executive functioning and the metabolic syndrome: a project frontier study. Archives of Clinical Neuropsychology 2014;29:47–53.

81. Scuteri A, Spazzafumo L, Cipriani L, et al. Depression, hypertension, and comorbidity: disentangling their specific effect on disability and cognitive impairment in older subjects. Arch Gerontol Geriatr 2011;52:253–7.

82. Bendini C, Angelini A, Salsi F, et al. Relation of neurocardiovascular instability to cognitive, emotional and functional domains. Arch Gerontol Geriatr 2007;44:69–74.

83. Turrell G, Lynch JW, Kaplan GA, et al. Socioeconomic position across the lifecourse and cognitive function in late middle age. J Gerontol B Psychol Sci Soc Sci 2002;57:S43–S51.

84. Dowling NM, Gleason CE, Manson JE, et al. Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance. PLoS One 2013;8:e68741.

85. Dik MG, Jonker C, Comijs HC, et al. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007;30:2655–60.

86. Love S, Miners S. Cerebrovascular disease in ageing and alzheimer’s disease acta neuropathologica. 2016;131:645–58.

87. Stephan BCM, Brayne C. Assessing the risk of dementia in the aging population. Nat Rev Neurol 2009;5:417–8.

88. Kalmijn S, Foley D, White L, et al. Metabolic cardiovascular syndrome and risk of dementia in japanese-american elderly men. Arterioscler Thromb Vasc Biol 2000;20:2255–60.

89. Luchsinger JA, Reitz C, Honig LS, et al. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005;65:545–51.

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from

Page 22: Open access Research Combining modifiable risk …2 Peters r etfial M Open 20199e022846 doi101136/bmjopen2018022846 Open access reduction strategies for cognitive decline and dementia

22 Peters R, et al. BMJ Open 2019;9:e022846. doi:10.1136/bmjopen-2018-022846

Open access

90. Reis JP, Loria CM, Launer LJ, et al. Cardiovascular health through young adulthood and cognitive functioning in midlife. Ann Neurol 2013;73:170–9.

91. Gardener H, Wright CB, Dong C, et al. Ideal cardiovascular health and cognitive aging in the northern manhattan study. J Am Heart Assoc 2016;5:e002731.

92. Hildreth KL, Grigsby J, Bryant LL, et al. Cognitive decline and cardiometabolic risk among Hispanic and non-Hispanic white adults in the San Luis Valley Health and Aging Study. J Behav Med 2014;37:332–42.

93. Whitmer RA, Sidney S, Selby J, et al. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005;64:277–81.

94. Schneider BC, Gross AL, Bangen KJ, et al. Association of vascular risk factors with cognition in a multiethnic sample. J Gerontol B Psychol Sci Soc Sci 2015;70:532–44.

95. Norton MC, Dew J, Smith H, et al. Lifestyle behavior pattern is associated with different levels of risk for incident dementia and alzheimer’s disease : the cache county study. J Am Geriatr Soc 2012;60:405–12.

96. Elias MF, Elias PK, Sullivan LM, et al. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes 2003;27:260–8.

97. Scarmeas N, et al. Physical activity, diet, and risk of alzheimer disease. JAMA 2009;302:627–37.

98. Rönnemaa E, Zethelius B, Lannfelt L, et al. Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dement Geriatr Cogn Disord 2011;31:460–6.

99. Persson N, Viitanen M, Almkvist O, et al. A principal component model of medical health: Implications for cognitive deficits and decline among adults in a population-based sample. J Health Psychol 2013;18:1268–87.

100. Qiu C, Xu W, Winblad B, et al. Vascular risk profiles for dementia and alzheimer’s disease in very old people : a population-based longitudinal study. Journal of Alzheimer’s Disease 2010;20:293–300.

101. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and alzheimer disease. Arch Neurol 2005;62:1556–60.

102. Reijmer YD, van den Berg E, van Sonsbeek S, et al. Dementia risk score predicts cognitive impairment after a period of 15 years in a nondemented population. Dement Geriatr Cogn Disord 2011;31:152–7.

103. Schiepers OJG, Köhler S, Deckers K, et al. Lifestyle for Brain Health (LIBRA): a new model for dementia prevention. Int J Geriatr Psychiatry 2018;33.

104. Hessler JB, Ander KH, Brönner M, et al. Predicting dementia in primary care patients with a cardiovascular health metric: a prospective population-based study. BMC Neurol 2016;16:116.

105. Kesse-Guyot E, Andreeva VA, Lassale C, et al. Clustering of midlife lifestyle behaviors and subsequent cognitive function: a longitudinal study. Am J Public Health 2014;104:e170–e177.

106. Hagger-Johnson G, Sabia S, Brunner EJ, et al. Combined impact of smoking and heavy alcohol use on cognitive decline in early old age: Whitehall II prospective cohort study. Br J Psychiatry 2013;203:120–5.

107. Sabia S, Nabi H, Kivimaki M, et al. Health behaviors from early to late midlife as predictors of cognitive function: The Whitehall II study. Am J Epidemiol 2009;170:428–37.

108. Anstey KJ, Sargent-Cox K, Garde E, et al. Cognitive development over 8 years in midlife and its association with cardiovascular risk factors. Neuropsychology 2014;28:653–65.

109. Lee Y, Kim J, Back JH. The influence of multiple lifestyle behaviors on cognitive function in older persons living in the community. Prev Med 2009;48:86–90.

110. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data. with applications to meta-analysis, American Journal of Epidemioly 1992;135:1301–9.

111. Stocks T, Bjørge T, Ulmer H, et al. Metabolic risk score and cancer risk: pooled analysis of seven cohorts. Int J Epidemiol 2015;44:1353–63.

112. Ding D, Rogers K, van der Ploeg H, et al. Traditional and emerging lifestyle risk behaviors and all-cause mortality in middle-aged and older adults: evidence from a large population-based Australian Cohort. PLoS Med 2015;12:e1001917.

113. Payne RA. Cardiovascular risk. Br J Clin Pharmacol 2012;74:396–410.

114. Damen JA, Hooft L, Schuit E, et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ 2016;353:i2416.

115. Gottesman RF, Schneider AL, Zhou Y, et al. Association between midlife vascular risk factors and estimated brain amyloid deposition. JAMA 2017;317:1443–50.

116. Peters R, Peters J, Booth A, et al. Is air pollution associated with increased risk of cognitive decline? A systematic review. Age Ageing 2015;44:755–60.

117. Clifford A, Lang L, Chen R, et al. Exposure to air pollution and cognitive functioning across the life course–A systematic literature review. Environ Res 2016;147:383–98.

118. Rovio SP, Pahkala K, Nevalainen J, et al. Cardiovascular risk factors from childhood and midlife cognitive performance. J Am Coll Cardiol 2017;69:2279–89.

119. Yang Z, Slavin MJ, Sachdev PS. Dementia in the oldest old. Nat Rev Neurol 2013;9:382–93.

120. Fontana L, Kennedy BK, Longo VD, et al. Medical research: treat ageing. Nature 2014;511:405–7.

121. Howlett SE, Rockwood K. Ageing: Develop models of frailty. Nature 2014;512:253.

122. Wallace LM, Theou O, Kirkland SA, et al. Accumulation of non-traditional risk factors for coronary heart disease is associated with incident coronary heart disease hospitalization and death. PLoS One 2014;9:e90475.

123. Zhang WB, Pincus Z. Predicting all-cause mortality from basic physiology in the Framingham Heart Study. Aging Cell 2016;15:39–48.

124. Song X, Mitnitski A, Rockwood K. Age-related deficit accumulation and the risk of late-life dementia. Alzheimers Res Ther 2014;6(5-8):54.

125. Armstrong JJ, Mitnitski A, Andrew MK, et al. Cumulative impact of health deficits, social vulnerabilities, and protective factors on cognitive dynamics in late life: a multistate modeling approach. Alzheimers Res Ther 2015;7:38.

126. Godin J, Armstrong JJ, Rockwood K, et al. Dynamics of frailty and cognition after age 50: why it matters that cognitive decline is mostly seen in old age. J Alzheimers Dis 2017;58:231–42.

127. López-Otín C, Blasco MA, Partridge L, et al. The hallmarks of aging. Cell 2013;153:1194–217.

128. Howlett SE, Rockwood K. New horizons in frailty: ageing and the deficit-scaling problem. Age Ageing 2013;42:416–23.

129. Mitnitski A, Collerton J, Martin-Ruiz C, et al. Age-related frailty and its association with biological markers of ageing. BMC Med 2015;13:161.

130. Howlett SE, Rockwood MR, Mitnitski A, et al. Standard laboratory tests to identify older adults at increased risk of death. BMC Med 2014;12:171.

131. Wallace LM, Ferrara M, Brothers TD, et al. Lower frailty is associated with successful cognitive aging among older adults with HIV. AIDS Res Hum Retroviruses 2017;33:157–63.

132. Schoufour JD, Mitnitski A, Rockwood K, et al. Predicting disabilities in daily functioning in older people with intellectual disabilities using a frailty index. Res Dev Disabil 2014;35:2267–77.

133. Davis DH, Muniz-Terrera G, Keage HA, et al. Association of delirium with cognitive decline in late life: a neuropathologic study of 3 population-based cohort studies. JAMA Psychiatry 2017;74:244–51.

on June 23, 2020 by guest. Protected by copyright.

http://bmjopen.bm

j.com/

BM

J Open: first published as 10.1136/bm

jopen-2018-022846 on 25 January 2019. Dow

nloaded from